1
|
McKaige EA, Lee C, Calcinotto V, Giri S, Crawford S, McGrath MJ, Ramm G, Bryson-Richardson RJ. Mitochondrial abnormalities contribute to muscle weakness in a Dnajb6 deficient zebrafish model. Hum Mol Genet 2024:ddae061. [PMID: 38621658 DOI: 10.1093/hmg/ddae061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Revised: 02/28/2024] [Accepted: 03/28/2024] [Indexed: 04/17/2024] Open
Abstract
Mutations in DNAJB6 are a well-established cause of limb girdle muscular dystrophy type D1 (LGMD D1). Patients with LGMD D1 develop progressive muscle weakness with histology showing fibre damage, autophagic vacuoles, and aggregates. Whilst there are many reports of LGMD D1 patients, the role of DNAJB6 in the muscle is still unclear. In this study, we developed a loss of function zebrafish model in order to investigate the role of Dnajb6. Using a double dnajb6a and dnajb6b mutant model, we show that loss of Dnajb6 leads to a late onset muscle weakness. Interestingly, we find that adult fish lacking Dnajb6 do not have autophagy or myofibril defects, however, they do show mitochondrial changes and damage. This study demonstrates that loss of Dnajb6 causes mitochondrial defects and suggests that this contributes to muscle weakness in LGMD D1. These findings expand our knowledge of the role of Dnajb6 in the muscle and provides a model to screen novel therapies for LGMD D1.
Collapse
Affiliation(s)
- Emily A McKaige
- School of Biological Sciences Monash University, 25 Rainforest Walk, Clayton, VIC 3800, Australia
| | - Clara Lee
- School of Biological Sciences Monash University, 25 Rainforest Walk, Clayton, VIC 3800, Australia
| | - Vanessa Calcinotto
- School of Biological Sciences Monash University, 25 Rainforest Walk, Clayton, VIC 3800, Australia
| | - Saveen Giri
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia
| | - Simon Crawford
- Monash Ramaciotti Centre for Cryo Electron Microscopy, Monash University, 15 Innovation Walk, Clayton, VIC 3800, Australia
| | - Meagan J McGrath
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia
| | - Georg Ramm
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia
- Monash Ramaciotti Centre for Cryo Electron Microscopy, Monash University, 15 Innovation Walk, Clayton, VIC 3800, Australia
| | | |
Collapse
|
2
|
He R, Hornberger LK, Kaur A, Crawford S, Boehme C, McBrien A, Eckersley L. Risk of major congenital heart disease in pregestational maternal diabetes is modified by hemoglobin A1c. Ultrasound Obstet Gynecol 2024; 63:378-384. [PMID: 37594210 DOI: 10.1002/uog.27456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Revised: 07/26/2023] [Accepted: 08/04/2023] [Indexed: 08/19/2023]
Abstract
OBJECTIVES The association between pregestational diabetes mellitus (PDM) and risk of congenital heart disease (CHD) is well recognized; however, the importance of glycemic control and other coexisting risk factors during pregnancy is less clear. We sought to determine the relative risk (RR) of major CHD (mCHD) among offspring from pregnancies complicated by PDM and the effect of first-trimester glycemic control on mCHD risk. METHODS We determined the incidence of mCHD (requiring surgery within 1 year of birth or resulting in pregnancy termination or fetal demise) among registered births in Alberta, Canada. Linkage of diabetes status, maximum hemoglobin A1c (HbA1c) at < 16 weeks' gestation and other covariates was performed using data from the Alberta Perinatal Health Program registry. Risk of mCHD according to HbA1c was estimated as an adjusted RR (aRR), calculated using log-binomial modeling. RESULTS Of 1412 cases of mCHD in 594 773 (2.37/1000) births in the study period, mCHD was present in 48/7497 with PDM (6.4/1000; RR, 2.8 (95% CI, 2.1-3.7); P < 0.0001). In the entire cohort, increased maternal age (aRR, 1.03 (95% CI, 1.02-1.04); P < 0.0001) and multiple gestation (aRR, 1.37 (95% CI, 1.1-1.8); P = 0.02) were also associated with mCHD risk, whereas maternal prepregnancy weight > 91 kg was not. The stratified risk for mCHD associated with HbA1c ≤ 6.1%, > 6.1-8.0% and > 8.0% was 4.2/1000, 6.8/1000 and 17.1/1000 PDM/gestational diabetes mellitus births, respectively; the aRR of mCHD associated with PDM and HbA1c > 8.0% was 8.5 (95% CI, 5.0-14.4) compared to those without diabetes and 5.5 (95% CI, 1.6-19.4) compared to PDM with normal HbA1c (≤ 6.1%). CONCLUSIONS PDM is associated with a RR of 2.8 for mCHD, increasing to 8.5 in those with HbA1c > 8%. These data should facilitate refinement of referral indications for high-risk pregnancy screening. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Collapse
Affiliation(s)
- R He
- Fetal & Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Women & Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada
| | - L K Hornberger
- Fetal & Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Women & Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada
| | - A Kaur
- Fetal & Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Women & Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada
| | - S Crawford
- Alberta Perinatal Health Program, Alberta Health Services, AB, Canada
| | - C Boehme
- Fetal & Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Women & Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada
| | - A McBrien
- Fetal & Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Women & Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada
| | - L Eckersley
- Fetal & Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Women & Children's Health Research Institute, University of Alberta, Edmonton, AB, Canada
| |
Collapse
|
3
|
Sourris KC, Ding Y, Maxwell SS, Al-Sharea A, Kantharidis P, Mohan M, Rosado CJ, Penfold SA, Haase C, Xu Y, Forbes JM, Crawford S, Ramm G, Harcourt BE, Jandeleit-Dahm K, Advani A, Murphy AJ, Timmermann DB, Karihaloo A, Knudsen LB, El-Osta A, Drucker DJ, Cooper ME, Coughlan MT. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation. Kidney Int 2024; 105:132-149. [PMID: 38069998 DOI: 10.1016/j.kint.2023.09.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 09/16/2023] [Accepted: 09/25/2023] [Indexed: 01/07/2024]
Abstract
Glucagon like peptide-1 (GLP-1) is a hormone produced and released by cells of the gastrointestinal tract following meal ingestion. GLP-1 receptor agonists (GLP-1RA) exhibit kidney-protective actions through poorly understood mechanisms. Here we interrogated whether the receptor for advanced glycation end products (RAGE) plays a role in mediating the actions of GLP-1 on inflammation and diabetic kidney disease. Mice with deletion of the GLP-1 receptor displayed an abnormal kidney phenotype that was accelerated by diabetes and improved with co-deletion of RAGE in vivo. Activation of the GLP-1 receptor pathway with liraglutide, an anti-diabetic treatment, downregulated kidney RAGE, reduced the expansion of bone marrow myeloid progenitors, promoted M2-like macrophage polarization and lessened markers of kidney damage in diabetic mice. Single cell transcriptomics revealed that liraglutide induced distinct transcriptional changes in kidney endothelial, proximal tubular, podocyte and macrophage cells, which were dominated by pathways involved in nutrient transport and utilization, redox sensing and the resolution of inflammation. The kidney-protective action of liraglutide was corroborated in a non-diabetic model of chronic kidney disease, the subtotal nephrectomised rat. Thus, our findings identify a novel glucose-independent kidney-protective action of GLP-1-based therapies in diabetic kidney disease and provide a valuable resource for exploring the cell-specific kidney transcriptional response ensuing from pharmacological GLP-1R agonism.
Collapse
Affiliation(s)
- Karly C Sourris
- Department of Diabetes, Monash University, Central Clinical School, Alfred Research Alliance, Melbourne, Victoria, Australia; Diabetes Complications Division, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
| | - Yi Ding
- Diabetes Complications Division, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia; Diabetes Complications Research, Novo Nordisk, Måløv, Denmark
| | - Scott S Maxwell
- Epigenetics in Human Health and Disease Program, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
| | - Annas Al-Sharea
- Haematopoiesis and Leukocyte Biology, Division of Immunometabolism, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
| | - Phillip Kantharidis
- Department of Diabetes, Monash University, Central Clinical School, Alfred Research Alliance, Melbourne, Victoria, Australia
| | - Muthukumar Mohan
- Department of Diabetes, Monash University, Central Clinical School, Alfred Research Alliance, Melbourne, Victoria, Australia
| | - Carlos J Rosado
- Department of Diabetes, Monash University, Central Clinical School, Alfred Research Alliance, Melbourne, Victoria, Australia
| | - Sally A Penfold
- Diabetes Complications Division, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
| | - Claus Haase
- Diabetes Complications Research, Novo Nordisk, Måløv, Denmark
| | - Yangsong Xu
- Haematopoiesis and Leukocyte Biology, Division of Immunometabolism, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
| | - Josephine M Forbes
- Mater Research Institute, the University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia
| | - Simon Crawford
- Monash Ramaciotti Centre for Cryo Electron Microscopy, Monash University, Clayton, Victoria, Australia
| | - Georg Ramm
- Monash Ramaciotti Centre for Cryo Electron Microscopy, Monash University, Clayton, Victoria, Australia
| | - Brooke E Harcourt
- Murdoch Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia
| | - Karin Jandeleit-Dahm
- Department of Diabetes, Monash University, Central Clinical School, Alfred Research Alliance, Melbourne, Victoria, Australia
| | - Andrew Advani
- Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St. Michaels Hospital, Toronto, Ontario, Canada
| | - Andrew J Murphy
- Haematopoiesis and Leukocyte Biology, Division of Immunometabolism, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
| | | | - Anil Karihaloo
- Novo Nordisk Research Center Seattle, Inc., Seattle, Washington, USA
| | | | - Assam El-Osta
- Epigenetics in Human Health and Disease Program, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia
| | - Daniel J Drucker
- Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
| | - Mark E Cooper
- Department of Diabetes, Monash University, Central Clinical School, Alfred Research Alliance, Melbourne, Victoria, Australia
| | - Melinda T Coughlan
- Department of Diabetes, Monash University, Central Clinical School, Alfred Research Alliance, Melbourne, Victoria, Australia; Diabetes Complications Division, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University Parkville Campus, Parkville, Victoria, Australia.
| |
Collapse
|
4
|
Olivier FAB, Hilsenstein V, Weerasinghe H, Weir A, Hughes S, Crawford S, Vince JE, Hickey MJ, Traven A. The escape of Candida albicans from macrophages is enabled by the fungal toxin candidalysin and two host cell death pathways. Cell Rep 2022; 40:111374. [PMID: 36130496 DOI: 10.1016/j.celrep.2022.111374] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2021] [Revised: 06/15/2022] [Accepted: 08/26/2022] [Indexed: 11/25/2022] Open
Abstract
The egress of Candida hyphae from macrophages facilitates immune evasion, but it also alerts macrophages to infection and triggers inflammation. To better define the mechanisms, here we develop an imaging assay to directly and dynamically quantify hyphal escape and correlate it to macrophage responses. The assay reveals that Candida escapes by using two pore-forming proteins to permeabilize macrophage membranes: the fungal toxin candidalysin and Nlrp3 inflammasome-activated Gasdermin D. Candidalysin plays a major role in escape, with Nlrp3 and Gasdermin D-dependent and -independent contributions. The inactivation of Nlrp3 does not reduce hyphal escape, and we identify ETosis via macrophage extracellular trap formation as an additional pathway facilitating hyphal escape. Suppressing hyphal escape does not reduce fungal loads, but it does reduce inflammatory activation. Our findings explain how Candida escapes from macrophages by using three strategies: permeabilizing macrophage membranes via candidalysin and engaging two host cell death pathways, Gasdermin D-mediated pyroptosis and ETosis.
Collapse
Affiliation(s)
- Françios A B Olivier
- Infection Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800 VIC, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia
| | | | - Harshini Weerasinghe
- Infection Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800 VIC, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia
| | - Ashley Weir
- The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC 3052, Australia; The Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Sebastian Hughes
- The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC 3052, Australia; The Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Simon Crawford
- Monash Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Clayton, VIC 3800, Australia
| | - James E Vince
- The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Parkville, VIC 3052, Australia; The Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Michael J Hickey
- Monash Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, VIC 3168, Australia
| | - Ana Traven
- Infection Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton 3800 VIC, Australia; Centre to Impact AMR, Monash University, Clayton, VIC 3800, Australia.
| |
Collapse
|
5
|
Han ML, Nang SC, Lin YW, Zhu Y, Yu HH, Wickremasinghe H, Barlow CK, Creek DJ, Crawford S, Rao G, Dai C, Barr JJ, Chan K, Turner Schooley R, Velkov T, Li J. Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination. Comput Struct Biotechnol J 2022; 20:485-495. [PMID: 35070170 PMCID: PMC8760530 DOI: 10.1016/j.csbj.2021.12.039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2021] [Revised: 12/28/2021] [Accepted: 12/30/2021] [Indexed: 01/21/2023] Open
Abstract
Resistance to the last-line polymyxins is emerging in multidrug-resistant Klebsiella pneumoniae and phage therapy is a promising alternative. However, phage monotherapy often rapidly causes resistance and few studies have examined antibiotic-phage combinations against K. pneumoniae. Here, we investigated the combination of polymyxin B with a novel phage pK8 against an mcr-1-carrying polymyxin-resistant clinical isolate Kp II-503 (polymyxin B MIC, 8 mg/L). The phage genome was sequenced and bacterial metabolomes were analysed at 4 and 24 h following the treatment with polymyxin B (16 mg/L), phage pK8 (102 PFU/mL) and their combination. Minimal metabolic changes across 24 h were observed with polymyxin B alone; whereas a significant inhibition of the citrate cycle, pentose phosphate pathway, amino acid and nucleotide metabolism occurred with the phage-polymyxin combination at both 4 and 24 h, but with phage alone only at 4 h. The development of resistance to phage alone was associated with enhanced membrane lipid and decreased amino acid biosynthesis in Kp II-503. Notably, cAMP, cGMP and cCMP were significantly enriched (3.1–6.6 log2fold) by phage alone and the combination only at 4 h. This is the first systems pharmacology study to investigate the enhanced bacterial killing by polymyxin-phage combination and provides important mechanistic information on phage killing, resistance and antibiotic-phage combination in K. pneumoniae.
Collapse
|
6
|
Soto Puelles J, Ghorbani M, Crawford S, Ackland ML, Chen F, Forsyth M, Somers AE. Modelling cetrimonium micelles as 4-OH cinnamate carriers targeting a hydrated iron oxide surface. J Colloid Interface Sci 2021; 610:785-795. [PMID: 34876264 DOI: 10.1016/j.jcis.2021.11.139] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Revised: 11/21/2021] [Accepted: 11/22/2021] [Indexed: 10/19/2022]
Abstract
HYPOTHESIS Molecular interactions between 4-OH-cinnamate and cetrimonium in solution result in improved adsorption of the cinnamate on mild steel, developing a protective mechanism against the diffusion of corrosive chloride to the oxide surface. Fundamental understanding of this mechanism should allow new design routes for the development of eco-friendly corrosion inhibitors. EXPERIMENTS Via classic molecular dynamics, simulations were carried out for cetrimonium and 4-OH-cinnamate in aqueous solutions at different ionic strengths and the results were validated with experimental SAXS data. Self-aggregation of cetrimonium 4-OH-cinnamate on a hydrated hematite surface was then simulated and results were compared with cryo-TEM imaging for the same compound. Finally, the effect of the adsorbed aggregates on chloride diffusion to the oxide surface was modelled. FINDINGS Simulations showed the encapsulation of 4-OH-cinnamate into cetrimonium micelles, consistent with experiments. The newly formed micelles adsorb onto a hydrated iron oxide surface by forming hydrogen bonds between their carboxylate outer-shell groups and the surface hydroxyls. As the adsorbate concentrations increase, there is a morphological transition from spherical to wormlike adsorbed aggregates. The wormlike structure can block chloride ions, demonstrating a synergistic inhibitory mechanism between both cetrimonium and 4-OH-cinnamate. Encapsulation and delivery of active compounds to certain targets, such as carcinogenic tumors, have been well studied in biochemistry research, we demonstrate that the same mechanism can be applied to the design of efficient corrosion inhibitors, optimizing their delivery to the metal surface.
Collapse
Affiliation(s)
| | - Mahdi Ghorbani
- Institute for Frontier Materials, Deakin University, Geelong, VIC 3217, Australia
| | - Simon Crawford
- Ramaciotti Centre for Cryo Electron Microscopy, Monash University, Clayton Campus, VIC 3800, Australia
| | - M Leigh Ackland
- Institute for Frontier Materials, Deakin University, Geelong, VIC 3217, Australia; School of Life and Environmental Sciences, Deakin University, Burwood, VIC 3125, Australia
| | - Fangfang Chen
- Institute for Frontier Materials, Deakin University, Geelong, VIC 3217, Australia; ARC Centre of Excellence for Electromaterials Science (ACES), Deakin University, Burwood 3125, Australia.
| | - Maria Forsyth
- Institute for Frontier Materials, Deakin University, Geelong, VIC 3217, Australia; ARC Centre of Excellence for Electromaterials Science (ACES), Deakin University, Burwood 3125, Australia.
| | - Anthony E Somers
- Institute for Frontier Materials, Deakin University, Geelong, VIC 3217, Australia.
| |
Collapse
|
7
|
Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL, Wilkins S, Shackleford DM, Charman SA, Bal W, Zawisza IA, Kurowska E, Gundlach AL, Ma S, Bush AI, Hare DJ, Doble PA, Crawford S, Gautier ECL, Parsons J, Huggins P, Barnham KJ, Cherny RA. Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta Neuropathol Commun 2021; 9:161. [PMID: 34588001 PMCID: PMC8482648 DOI: 10.1186/s40478-021-01258-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
8
|
Parker AM, Tate M, Prakoso D, Deo M, Willis AM, Nash DM, Donner DG, Crawford S, Kiriazis H, Granata C, Coughlan MT, De Blasio MJ, Ritchie RH. Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy. Front Physiol 2021; 12:672252. [PMID: 34539423 PMCID: PMC8442993 DOI: 10.3389/fphys.2021.672252] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Accepted: 08/10/2021] [Indexed: 12/26/2022] Open
Abstract
People affected by diabetes are at an increased risk of developing heart failure than their non-diabetic counterparts, attributed in part to a distinct cardiac pathology termed diabetic cardiomyopathy. Mitochondrial dysfunction and excess reactive oxygen species (ROS) have been implicated in a range of diabetic complications and are a common feature of the diabetic heart. In this study, we sought to characterise impairments in mitochondrial structure and function in a recently described experimental mouse model of diabetic cardiomyopathy. Diabetes was induced in 6-week-old male FVB/N mice by the combination of three consecutive-daily injections of low-dose streptozotocin (STZ, each 55 mg/kg i.p.) and high-fat diet (42% fat from lipids) for 26 weeks. At study end, diabetic mice exhibited elevated blood glucose levels and impaired glucose tolerance, together with increases in both body weight gain and fat mass, replicating several aspects of human type 2 diabetes. The myocardial phenotype of diabetic mice included increased myocardial fibrosis and left ventricular (LV) diastolic dysfunction. Elevated LV superoxide levels were also evident. Diabetic mice exhibited a spectrum of LV mitochondrial changes, including decreased mitochondria area, increased levels of mitochondrial complex-III and complex-V protein abundance, and reduced complex-II oxygen consumption. In conclusion, these data suggest that the low-dose STZ-high fat experimental model replicates some of the mitochondrial changes seen in diabetes, and as such, this model may be useful to study treatments that target the mitochondria in diabetes.
Collapse
Affiliation(s)
- Alex M Parker
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.,Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.,Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia
| | - Mitchel Tate
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.,Baker Heart & Diabetes Institute, Melbourne, VIC, Australia
| | - Darnel Prakoso
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.,Baker Heart & Diabetes Institute, Melbourne, VIC, Australia
| | - Minh Deo
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia
| | - Andrew M Willis
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia
| | - David M Nash
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia
| | - Daniel G Donner
- Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.,Baker Department of Cardiometabolic Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Simon Crawford
- Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Melbourne, VIC, Australia
| | - Helen Kiriazis
- Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.,Baker Department of Cardiometabolic Health, The University of Melbourne, Melbourne, VIC, Australia
| | - Cesare Granata
- Department of Diabetes, Monash University, Melbourne, VIC, Australia.,Institute for Health and Sport, Victoria University, Melbourne, VIC, Australia
| | | | - Miles J De Blasio
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.,Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.,Department of Pharmacology, Monash University, Melbourne, VIC, Australia
| | - Rebecca H Ritchie
- Heart Failure Pharmacology, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.,Baker Heart & Diabetes Institute, Melbourne, VIC, Australia.,Department of Pharmacology and Therapeutics, The University of Melbourne, Melbourne, VIC, Australia.,Department of Pharmacology, Monash University, Melbourne, VIC, Australia
| |
Collapse
|
9
|
Vidallon MLP, Giles LW, Crawford S, Bishop AI, Tabor RF, de Campo L, Teo BM. Exploring the transition of polydopamine-shelled perfluorohexane emulsion droplets into microbubbles using small- and ultra-small-angle neutron scattering. Phys Chem Chem Phys 2021; 23:9843-9850. [PMID: 33908524 DOI: 10.1039/d1cp01146d] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Perfluorocarbon emulsion droplets are interesting colloidal systems with applications, ranging from diagnostics and theranostics to drug delivery, due to their controllable phase transition into microbubbles via heat application or acoustic droplet vapourisation. This work highlights the application of small- and ultra-small-angle neutron scattering (SANS and USANS, respectively), in combination with contrast variation techniques, in observing the in situ phase transition of polydopamine-stabilised perfluorohexane (PDA/PFH) emulsion droplets into microbubbles during heating. Results show peak USANS intensities at temperatures around 90 °C, which indicates that the phase transition of PDA/PFH emulsion droplets occurs at significantly higher temperatures than the bulk boiling point of pure liquid PFH (56 °C). Analysis and model fitting of the SANS and USANS data allowed us to estimate droplet sizes and interfacial properties at different temperatures (20 °C, 90 °C, and 20 °C after cooling), giving valuable insights about the transformation of these polydisperse emulsion droplet systems.
Collapse
|
10
|
Hussein M, Hu X, Paulin OK, Crawford S, Tony Zhou Q, Baker M, Schneider-Futschik EK, Zhu Y, Li J, Velkov T. Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens. Comput Struct Biotechnol J 2020; 18:2247-2258. [PMID: 32952938 PMCID: PMC7481501 DOI: 10.1016/j.csbj.2020.08.008] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2020] [Revised: 08/08/2020] [Accepted: 08/09/2020] [Indexed: 12/19/2022] Open
Abstract
The status quo for combating uprising antibacterial resistance is to employ synergistic combinations of antibiotics. Nevertheless, the currently available combination therapies are fast becoming untenable. Combining antibiotics with various FDA-approved non-antibiotic drugs has emerged as a novel strategy against otherwise untreatable multi-drug resistant (MDR) pathogens. The apex of this study was to investigate the mechanisms of antibacterial synergy of the combination of polymyxin B with the phenothiazines against the MDR Gram-negative pathogens Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa. The synergistic antibacterial effects were tested using checkerboard and static time-kill assays. Electron microscopy (EM) and untargeted metabolomics were used to ascertain the mechanism(s) of the antibacterial synergy. The combination of polymyxin B and the phenothiazines showed synergistic antibacterial activity in checkerboard and static time-kill assays at clinically relevant concentrations against both polymyxin-susceptible and polymyxin-resistant isolates. EM revealed that the polymyxin B-prochlorperazine combination resulted in greater damage to the bacterial cell compared to each drug monotherapy. In metabolomics, at 0.5 h, polymyxin B monotherapy and the combination (to a greatest extent) disorganised the bacterial cell envelope as manifested by a major perturbation in bacterial membrane lipids (glycerophospholipids and fatty acids), peptidoglycan and lipopolysaccharide (LPS) biosynthesis. At the late time exposure (4 h), the aforementioned effects (except LPS biosynthesis) perpetuated mainly with the combination therapy, indicating the disorganising bacterial membrane biogenesis is potentially behind the mechanisms of antibacterial synergy. In conclusion, the study highlights the potential usefulness of the combination of polymyxin B with phenothiazines for the treatment of polymyxin-resistant Gram-negative infections (e.g. CNS infections).
Collapse
Affiliation(s)
- Maytham Hussein
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia
| | - Xiaohan Hu
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia
| | - Olivia K.A. Paulin
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia
| | - Simon Crawford
- The Monash Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Clayton, Victoria 3800, Australia
| | - Qi Tony Zhou
- Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, IN 47907-2091, USA
| | - Mark Baker
- Discipline of Biological Sciences, Priority Research Centre in Reproductive Biology, Faculty of Science and IT, University of Newcastle, University Drive, Callaghan NSW, 2308, Australia
| | - Elena K. Schneider-Futschik
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia
| | - Yan Zhu
- Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia
| | - Jian Li
- Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia
| | - Tony Velkov
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, VIC 3010, Australia
| |
Collapse
|
11
|
Hussein M, Schneider-Futschik EK, Paulin OKA, Allobawi R, Crawford S, Zhou QT, Hanif A, Baker M, Zhu Y, Li J, Velkov T. Effective Strategy Targeting Polymyxin-Resistant Gram-Negative Pathogens: Polymyxin B in Combination with the Selective Serotonin Reuptake Inhibitor Sertraline. ACS Infect Dis 2020; 6:1436-1450. [PMID: 32427476 DOI: 10.1021/acsinfecdis.0c00108] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
This study aimed to investigate synergistic antibacterial activity of polymyxin B in combination with the selective serotonin reuptake inhibitor, sertraline, against the Gram-negative pathogens Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The combination of polymyxin B and sertraline showed synergistic antibacterial activity in checkerboard and static time-kill assays at clinically relevant concentrations against both polymyxin-susceptible and polymyxin-resistant isolates. The potential antimicrobial mode of action of the combination was investigated against P. aeruginosa FADDI-PA024 using untargeted metabolomics alongside scanning and transmission electron microscopy (EM). Scanning and transmission EM revealed that the polymyxin B and sertraline combination resulted in greater damage to the bacterial cell compared to each drug alone. Metabolomics results showed that the combination significantly affected the bacterial ability to remodel its outer membrane. This was reflected by the major perturbation of glycerophospholipids and fatty acids and the pantothenate and coenzyme A (CoA) pathways, which feed fatty acid elongation (e.g., trans-hexadec-2-enoyl-CoA) as well as inhibit the biosynthesis of lipopolysaccharide and peptidoglycan. The combination also inhibited the polymyxin resistance phosphoethanolamine (pEtN) lipid A modification pathway, indicated by the declined levels of phosphoethanolamine. In summary, the present study highlights the potential possibilities of a polymyxin-sertraline combination for the treatment of infections caused by multidrug resistant Gram-negative bacteria such as central nervous system (CNS) infections via direct intraventricular/intrathecal delivery.
Collapse
Affiliation(s)
- Maytham Hussein
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Elena K. Schneider-Futschik
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Olivia K. A. Paulin
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Rafah Allobawi
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Simon Crawford
- The Monash Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Clayton, Victoria 3800, Australia
| | - Qi Tony Zhou
- Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907-2091, United States
| | - Adil Hanif
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| | - Mark Baker
- Discipline of Biological Sciences, Priority Research Centre in Reproductive Biology, Faculty of Science and IT, University of Newcastle, University Drive, Callaghan, New South Wales 2308, Australia
| | - Yan Zhu
- Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia
| | - Jian Li
- Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia
| | - Tony Velkov
- Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria 3010, Australia
| |
Collapse
|
12
|
Li J, Sun YBY, Chen W, Fan J, Li S, Qu X, Chen Q, Chen R, Zhu D, Zhang J, Wu Z, Chi H, Crawford S, Oorschot V, Puelles VG, Kerr PG, Ren Y, Nilsson SK, Christian M, Tang H, Chen W, Bertram JF, Nikolic-Paterson DJ, Yu X. Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS. EMBO Rep 2020; 21:e48781. [PMID: 31916354 DOI: 10.15252/embr.201948781] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Revised: 10/31/2019] [Accepted: 11/18/2019] [Indexed: 02/06/2023] Open
Abstract
Diabetic nephropathy (DN) is the leading cause of end-stage kidney disease. TGF-β1/Smad3 signalling plays a major pathological role in DN; however, the contribution of Smad4 has not been examined. Smad4 depletion in the kidney using anti-Smad4 locked nucleic acid halted progressive podocyte damage and glomerulosclerosis in mouse type 2 DN, suggesting a pathogenic role of Smad4 in podocytes. Smad4 is upregulated in human and mouse podocytes during DN. Conditional Smad4 deletion in podocytes protects mice from type 2 DN, independent of obesity. Mechanistically, hyperglycaemia induces Smad4 localization to mitochondria in podocytes, resulting in reduced glycolysis and oxidative phosphorylation and increased production of reactive oxygen species. This operates, in part, via direct binding of Smad4 to the glycolytic enzyme PKM2 and reducing the active tetrameric form of PKM2. In addition, Smad4 interacts with ATPIF1, causing a reduction in ATPIF1 degradation. In conclusion, we have discovered a mitochondrial mechanism by which Smad4 causes diabetic podocyte injury.
Collapse
Affiliation(s)
- Jinhua Li
- Shunde Women and Children Hospital, Guangdong Medical University, Shunde, Guangdong, China.,The Second Clinical College, Guangdong Medical University, Dongguan, Guangdong, China.,Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Vic., Australia.,Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Vic., Australia.,Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.,Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China
| | - Yu Bo Yang Sun
- Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Vic., Australia
| | - Weiyi Chen
- Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Vic., Australia
| | - Jinjin Fan
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.,Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China
| | - Songhui Li
- Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO), Melbourne, Vic., Australia.,Australian Regenerative Medicine Institute, Monash University, Clayton, Vic., Australia
| | - Xinli Qu
- Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Vic., Australia
| | - Qikang Chen
- Shunde Women and Children Hospital, Guangdong Medical University, Shunde, Guangdong, China
| | - Riling Chen
- Shunde Women and Children Hospital, Guangdong Medical University, Shunde, Guangdong, China
| | - Dajian Zhu
- Shunde Women and Children Hospital, Guangdong Medical University, Shunde, Guangdong, China
| | - Jinfeng Zhang
- Shunde Women and Children Hospital, Guangdong Medical University, Shunde, Guangdong, China
| | - Zhuguo Wu
- The Second Clinical College, Guangdong Medical University, Dongguan, Guangdong, China
| | - Honggang Chi
- The Second Clinical College, Guangdong Medical University, Dongguan, Guangdong, China
| | - Simon Crawford
- Monash Ramaciotti Cryo EM Platform, Monash Biomedicine Discovery Institute, Clayton, Vic., Australia
| | - Viola Oorschot
- Monash Ramaciotti Cryo EM Platform, Monash Biomedicine Discovery Institute, Clayton, Vic., Australia
| | - Victor G Puelles
- Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Vic., Australia.,III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.,Departments of Nephrology and Medicine, Monash Health and Monash University, Clayton, Vic., Australia
| | - Peter G Kerr
- Departments of Nephrology and Medicine, Monash Health and Monash University, Clayton, Vic., Australia
| | - Yi Ren
- Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL, USA
| | - Susan K Nilsson
- Biomedical Manufacturing Commonwealth Scientific and Industrial Research Organisation (CSIRO), Melbourne, Vic., Australia.,Australian Regenerative Medicine Institute, Monash University, Clayton, Vic., Australia
| | - Mark Christian
- School of Science and Technology, Nottingham Trent University, Clifton, Nottingham, UK
| | - Huanwen Tang
- Dongguan Key Laboratory of Environmental Medicine, Department of Preventive Medicine, School of Public Health, Guangdong Medical University, Dongguan, Guangdong, China
| | - Wei Chen
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.,Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China
| | - John F Bertram
- Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Vic., Australia
| | - David J Nikolic-Paterson
- Departments of Nephrology and Medicine, Monash Health and Monash University, Clayton, Vic., Australia
| | - Xueqing Yu
- Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
| |
Collapse
|
13
|
Wetherbee R, Rossetto Marcelino V, Costa JF, Grant B, Crawford S, Waller RF, Andersen RA, Berry D, McFadden GI, Verbruggen H. A new marine prasinophyte genus alternates between a flagellate and a dominant benthic stage with microrhizoids for adhesion. J Phycol 2019; 55:1210-1225. [PMID: 31393007 DOI: 10.1111/jpy.12909] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Accepted: 06/13/2019] [Indexed: 06/10/2023]
Abstract
Prasinophytes (Chlorophyta) are a diverse, paraphyletic group of planktonic microalgae for which benthic species are largely unknown. Here, we report a sand-dwelling, marine prasinophyte with several novel features observed in clonal cultures established from numerous locations around Australia. The new genus and species, which we name Microrhizoidea pickettheapsiorum (Mamiellophyceae), alternates between a benthic palmelloid colony, where cell division occurs, and a planktonic flagellate. Flagellates are short lived, settle and quickly resorb their flagella, the basal bodies then nucleate novel tubular appendages, termed "microrhizoids", that lack an axoneme and function to anchor benthic cells to the substratum. To our knowledge, microrhizoids have not been observed in any other green alga or protist, are slightly smaller in diameter than flagella, generally contain nine microtubules, are long (3-5 times the length of flagella) and are not encased in scales. Following settlement, cell divisions result in a loose, palmelloid colony, each cell connected to the substratum by two microrhizoids. Flagellates are round to bean-shaped with two long, slightly uneven flagella. Both benthic cells and flagellates, along with their flagella, are encased in thin scales. Phylogenies based on the complete chloroplast genome of Microrhizoidea show that it is clearly a member of the Mamiellophyceae, most closely related to Dolichomastix tenuilepsis. More taxon-rich phylogenetic analyses of the 18S rRNA gene, including metabarcodes from the Tara Oceans and Ocean Sampling Day projects, confidently show the distinctive nature of Microrhizoidea, and that the described biodiversity of the Mamiellophyceae is a fraction of its real biodiversity. The discovery of a largely benthic prasinophyte changes our perspective on this group of algae and, along with the observation of other potential benthic lineages in environmental sequences, illustrates that benthic habitats can be a rich ground for algal biodiscovery.
Collapse
Affiliation(s)
- Richard Wetherbee
- School of BioSciences, University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Vanessa Rossetto Marcelino
- Westmead Institute for Medical Research, The University of Sydney, Westmead, New South Wales, 2145, Australia
| | - Joana F Costa
- School of BioSciences, University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Brenna Grant
- School of BioSciences, University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Simon Crawford
- School of BioSciences, University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Ross F Waller
- Department of Biochemistry, University of Cambridge, Cambridge, UK
| | - Robert A Andersen
- Friday Harbor Laboratories, University of Washington, Seattle, Washington, USA
| | - Drew Berry
- The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, 3052, Australia
| | - Geoffrey I McFadden
- School of BioSciences, University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Heroen Verbruggen
- School of BioSciences, University of Melbourne, Parkville, Victoria, 3010, Australia
| |
Collapse
|
14
|
Byrne JJ, Soh MS, Chandhok G, Vijayaraghavan T, Teoh JS, Crawford S, Cobham AE, Yapa NMB, Mirth CK, Neumann B. Disruption of mitochondrial dynamics affects behaviour and lifespan in Caenorhabditis elegans. Cell Mol Life Sci 2019; 76:1967-1985. [PMID: 30840087 PMCID: PMC6478650 DOI: 10.1007/s00018-019-03024-5] [Citation(s) in RCA: 51] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2018] [Revised: 01/11/2019] [Accepted: 01/22/2019] [Indexed: 01/29/2023]
Abstract
Mitochondria are essential components of eukaryotic cells, carrying out critical physiological processes that include energy production and calcium buffering. Consequently, mitochondrial dysfunction is associated with a range of human diseases. Fundamental to their function is the ability to transition through fission and fusion states, which is regulated by several GTPases. Here, we have developed new methods for the non-subjective quantification of mitochondrial morphology in muscle and neuronal cells of Caenorhabditis elegans. Using these techniques, we uncover surprising tissue-specific differences in mitochondrial morphology when fusion or fission proteins are absent. From ultrastructural analysis, we reveal a novel role for the fusion protein FZO-1/mitofusin 2 in regulating the structure of the inner mitochondrial membrane. Moreover, we have determined the influence of the individual mitochondrial fission (DRP-1/DRP1) and fusion (FZO-1/mitofusin 1,2; EAT-3/OPA1) proteins on animal behaviour and lifespan. We show that loss of these mitochondrial fusion or fission regulators induced age-dependent and progressive deficits in animal movement, as well as in muscle and neuronal function. Our results reveal that disruption of fusion induces more profound defects than lack of fission on animal behaviour and tissue function, and imply that while fusion is required throughout life, fission is more important later in life likely to combat ageing-associated stressors. Furthermore, our data demonstrate that mitochondrial function is not strictly dependent on morphology, with no correlation found between morphological changes and behavioural defects. Surprisingly, we find that disruption of either mitochondrial fission or fusion significantly reduces median lifespan, but maximal lifespan is unchanged, demonstrating that mitochondrial dynamics play an important role in limiting variance in longevity across isogenic populations. Overall, our study provides important new insights into the central role of mitochondrial dynamics in maintaining organismal health.
Collapse
Affiliation(s)
- Joseph J Byrne
- Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia
| | - Ming S Soh
- Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia
| | - Gursimran Chandhok
- Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia
| | - Tarika Vijayaraghavan
- Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia
| | - Jean-Sébastien Teoh
- Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia
| | - Simon Crawford
- Monash Ramaciotti Centre for Cryo-Electron Microscopy, Monash University, Melbourne, VIC, 3800, Australia
| | - Ansa E Cobham
- School of Biological Sciences, Monash University, Melbourne, VIC, 3800, Australia
| | - Nethmi M B Yapa
- Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia
| | - Christen K Mirth
- School of Biological Sciences, Monash University, Melbourne, VIC, 3800, Australia
| | - Brent Neumann
- Neuroscience Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, 3800, Australia.
| |
Collapse
|
15
|
Wetherbee R, Jackson CJ, Repetti SI, Clementson LA, Costa JF, van de Meene A, Crawford S, Verbruggen H. The golden paradox - a new heterokont lineage with chloroplasts surrounded by two membranes. J Phycol 2019; 55:257-278. [PMID: 30536815 DOI: 10.1111/jpy.12822] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/06/2018] [Accepted: 10/23/2018] [Indexed: 06/09/2023]
Abstract
A marine, sand-dwelling, golden-brown alga is described from clonal cultures established from a high intertidal pool in southeastern Australia. This tiny, unicellular species, which we call the "golden paradox" (Chrysoparadoxa australica gen. et sp. nov.), is benthic, surrounded by a multilayered cell wall and attached to the substratum by a complex adhesive plug. Each vegetative cell gives rise to a single, naked zoospore with heterokont flagella that settles and may become briefly amoeboid prior to dividing. Daughter cells are initially amoeboid, then either permanently attach and return to the benthic stage or become motile again prior to final settlement. Two deeply lobed chloroplasts occupy opposite ends of the cell and are surrounded by only two membranes. The outer chloroplast membrane is continuous between the two chloroplasts via the outer membrane of the nuclear envelope. Only two membranes occupy the chloroplast-nucleus interface, the inner membrane of the nuclear envelope and the inner chloroplast membrane. A small pyrenoid is found in each chloroplast and closely abuts the nucleus or protrudes into it. It contains an unusual, membrane-bound inclusion that stains with SYBR green but is unlikely to be a nucleomorph. Phylogenies inferred from a 10-gene concatenated alignment show an early-branching position within the PX clade. The unusual morphological features and phylogenetic position indicate C. australica should be classified as a new class, Chrysoparadoxophyceae. Despite an atypical plastid, exploration of the C. australica transcriptome revealed typical heterokont protein targeting to the plastid.
Collapse
Affiliation(s)
- Richard Wetherbee
- School of BioSciences, University of Melbourne, Melbourne, Victoria, 3010, Australia
| | - Christopher J Jackson
- School of BioSciences, University of Melbourne, Melbourne, Victoria, 3010, Australia
| | - Sonja I Repetti
- School of BioSciences, University of Melbourne, Melbourne, Victoria, 3010, Australia
| | | | - Joana F Costa
- School of BioSciences, University of Melbourne, Melbourne, Victoria, 3010, Australia
| | - Allison van de Meene
- School of BioSciences, University of Melbourne, Melbourne, Victoria, 3010, Australia
| | - Simon Crawford
- School of BioSciences, University of Melbourne, Melbourne, Victoria, 3010, Australia
| | - Heroen Verbruggen
- School of BioSciences, University of Melbourne, Melbourne, Victoria, 3010, Australia
| |
Collapse
|
16
|
Samii L, Kallas-Koeman M, Donovan LE, Lodha A, Crawford S, Butalia S. The association between vascular complications during pregnancy in women with Type 1 diabetes and congenital malformations. Diabet Med 2019; 36:237-242. [PMID: 30499197 DOI: 10.1111/dme.13872] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/28/2018] [Indexed: 11/30/2022]
Abstract
AIMS To assess the association between vascular complications of diabetes and the risk of congenital malformations in pregnant women with Type 1 diabetes. METHODS We conducted an observational retrospective cohort study in women with Type 1 diabetes who received care consecutively from three tertiary care diabetes-in-pregnancy clinics in Calgary, Alberta, Canada. Multivariable logistic regression was used to assess the association between vascular complications (retinopathy, nephropathy and pre-existing hypertension) and congenital malformations in offspring of women with Type 1 diabetes. RESULTS Of 232 women with Type 1 diabetes, 49 (21%) had at least one vascular complication and there were 52 babies with congenital malformations. Maternal age (31.8 ± 5.0 vs. 29.4 ± 4.7 years, P < 0.01), diabetes duration (20.9 ± 6.7 vs. 11.2 ± 7.4 years, P < 0.01) and pre-eclampsia rate (12.5% vs. 1.3%, P < 0.01) were higher in mothers with vascular complications than in those without. Multivariable analyses showed that vascular complications were not associated with an increased risk of congenital malformations (odds ratio 1.16, 95% confidence interval 0.46 to 2.88). CONCLUSIONS Vascular complications are common, occurring in one-fifth of pregnant women with Type 1 diabetes, and in this study do not appear to be associated with an increased risk of congenital malformations in children.
Collapse
Affiliation(s)
- L Samii
- Department of Medicine, University of Calgary, Calgary Alberta, Canada
| | - M Kallas-Koeman
- Department of Medicine, University of Calgary, Calgary Alberta, Canada
| | - L E Donovan
- Department of Medicine, University of Calgary, Calgary Alberta, Canada
- Department of Obstetrics and Gynecology, University of Calgary, Calgary Alberta, Canada
| | - A Lodha
- Department of Community Health Sciences, University of Calgary, Calgary Alberta, Canada
- Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada
| | - S Crawford
- Alberta Perinatal Health Program, Alberta Health Services, Calgary Alberta, Canada
| | - S Butalia
- Department of Medicine, University of Calgary, Calgary Alberta, Canada
- Department of Community Health Sciences, University of Calgary, Calgary Alberta, Canada
- Libin Cardiovascular Institute, Calgary Alberta, Canada
- O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| |
Collapse
|
17
|
Chinnock B, Hendey G, Woolard R, Crawford S, Mainis L, Vo D, Wells R, Ramirez R, Bengiamin D. 148 Sensitivity of a Bedside Reagent Strip for the Detection of Spontaneous Bacterial Peritonitis in Emergency Patients With Ascites. Ann Emerg Med 2018. [DOI: 10.1016/j.annemergmed.2018.08.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
18
|
Cavanaugh S, Wei J, Law T, Dick J, Schantz P, Tsui T, Crawford S, Swanson J. EP-2184: Clinical Implementation of a Nomogram as a HDR Prostate Pre-Treatment Second Check. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)32493-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
19
|
Cavanaugh S, Crawford S, Dick J, Schantz P, Tsui T, Harpool K, Snyder W, Swanson J. PO-1027: Dosimetric Improvement in HDR Prostate Brachytherapy Patients using Hydrogel Spacer Implantation. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31337-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Gerkowicz S, Crawford S, Hipp H, Boulet S, Kissin D, Kawwass J. Assisted reproductive technology with donor sperm: national trends and perinatal outcomes. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.07.228] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
21
|
Preston S, Korhonen PK, Mouchiroud L, Cornaglia M, McGee SL, Young ND, Davis RA, Crawford S, Nowell C, Ansell BRE, Fisher GM, Andrews KT, Chang BCH, Gijs MAM, Sternberg PW, Auwerx J, Baell J, Hofmann A, Jabbar A, Gasser RB. Deguelin exerts potent nematocidal activity
via
the mitochondrial respiratory chain. FASEB J 2017; 31:4515-4532. [DOI: 10.1096/fj.201700288r] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2017] [Accepted: 06/12/2017] [Indexed: 12/14/2022]
Affiliation(s)
- Sarah Preston
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
- Faculty of Science and TechnologyFederation UniversityBallaratVictoriaAustralia
| | - Pasi K. Korhonen
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
| | - Laurent Mouchiroud
- Laboratory of Integrative and Systems PhysiologyÉcole Polytechnique Fédérale de LausanneLausanneSwitzerland
| | - Matteo Cornaglia
- Laboratory of MicrosystemsÉcole Polytechnique Fédérale de LausanneLausanneSwitzerland
| | - Sean L. McGee
- Metabolic Research UnitMetabolic Reprogramming LaboratorySchool of Medicine, Faculty of Health, Deakin UniversityWaurn PondsVictoriaAustralia
| | - Neil D. Young
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
| | - Rohan A. Davis
- Griffith Institute for Drug DiscoveryGriffith UniversityNathanQueenslandAustralia
| | - Simon Crawford
- School of Biosciences, University of MelbourneParkvilleVictoriaAustralia
| | - Cameron Nowell
- Drug Discovery BiologyMonash University Institute of Pharmaceutical SciencesMonash UniversityParkvilleVictoriaAustralia
| | - Brendan R. E. Ansell
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
| | - Gillian M. Fisher
- Griffith Institute for Drug DiscoveryGriffith UniversityNathanQueenslandAustralia
| | - Katherine T. Andrews
- Griffith Institute for Drug DiscoveryGriffith UniversityNathanQueenslandAustralia
| | - Bill C. H. Chang
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
- Yourgene BioscienceTaipeiTaiwan
| | - Martin A. M. Gijs
- Laboratory of MicrosystemsÉcole Polytechnique Fédérale de LausanneLausanneSwitzerland
| | - Paul W. Sternberg
- Division of Biology and Biological EngineeringCalifornia Institute of TechnologyPasadenaCaliforniaUSA
| | - Johan Auwerx
- Laboratory of Integrative and Systems PhysiologyÉcole Polytechnique Fédérale de LausanneLausanneSwitzerland
| | - Jonathan Baell
- Medicinal ChemistryMonash University Institute of Pharmaceutical SciencesMonash UniversityParkvilleVictoriaAustralia
| | - Andreas Hofmann
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
- Griffith Institute for Drug DiscoveryGriffith UniversityNathanQueenslandAustralia
| | - Abdul Jabbar
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
| | - Robin B. Gasser
- Faculty of Veterinary and Agricultural SciencesUniversity of MelbourneParkvilleVictoriaAustralia
| |
Collapse
|
22
|
Preston S, Jiao Y, Baell JB, Keiser J, Crawford S, Koehler AV, Wang T, Simpson MM, Kaplan RM, Cowley KJ, Simpson KJ, Hofmann A, Jabbar A, Gasser RB. Screening of the 'Open Scaffolds' collection from Compounds Australia identifies a new chemical entity with anthelmintic activities against different developmental stages of the barber's pole worm and other parasitic nematodes. Int J Parasitol Drugs Drug Resist 2017; 7:286-294. [PMID: 28732272 PMCID: PMC5517787 DOI: 10.1016/j.ijpddr.2017.05.004] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/03/2017] [Revised: 05/23/2017] [Accepted: 05/25/2017] [Indexed: 12/26/2022]
Abstract
The discovery and development of novel anthelmintic classes is essential to sustain the control of socioeconomically important parasitic worms of humans and animals. With the aim of offering novel, lead-like scaffolds for drug discovery, Compounds Australia released the 'Open Scaffolds' collection containing 33,999 compounds, with extensive information available on the physicochemical properties of these chemicals. In the present study, we screened 14,464 prioritised compounds from the 'Open Scaffolds' collection against the exsheathed third-stage larvae (xL3s) of Haemonchus contortus using recently developed whole-organism screening assays. We identified a hit compound, called SN00797439, which was shown to reproducibly reduce xL3 motility by ≥ 70%; this compound induced a characteristic, "coiled" xL3 phenotype (IC50 = 3.46-5.93 μM), inhibited motility of fourth-stage larvae (L4s; IC50 = 0.31-12.5 μM) and caused considerable cuticular damage to L4s in vitro. When tested on other parasitic nematodes in vitro, SN00797439 was shown to inhibit (IC50 = 3-50 μM) adults of Ancylostoma ceylanicum (hookworm) and first-stage larvae of Trichuris muris (whipworm) and eventually kill (>90%) these stages. Furthermore, this compound completely inhibited the motility of female and male adults of Brugia malayi (50-100 μM) as well as microfilariae of both B. malayi and Dirofilaria immitis (heartworm). Overall, these results show that SN00797439 acts against genetically (evolutionarily) distant parasitic nematodes i.e. H. contortus and A. ceylanicum [strongyloids] vs. B. malayi and D. immitis [filarioids] vs. T. muris [enoplid], and, thus, might offer a novel, lead-like scaffold for the development of a relatively broad-spectrum anthelmintic. Our future work will focus on assessing the activity of SN00797439 against other pathogens that cause neglected tropical diseases, optimising analogs with improved biological activities and characterising their targets.
Collapse
Affiliation(s)
- Sarah Preston
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia; Faculty of Science and Technology, Federation University, Ballarat, Victoria 3350, Australia
| | - Yaqing Jiao
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia
| | - Jonathan B Baell
- Monash University Institute of Pharmaceutical Sciences (MIPS), Monash University, Parkville, Victoria, Australia
| | - Jennifer Keiser
- Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland
| | - Simon Crawford
- School of Biosciences, The University of Melbourne, Parkville, Victoria, Australia
| | - Anson V Koehler
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia
| | - Tao Wang
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia
| | - Moana M Simpson
- Griffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, Queensland, Australia
| | - Ray M Kaplan
- Department of Infectious Diseases, College of Veterinary Medicine, The University of Georgia, Athens, GA, USA
| | - Karla J Cowley
- Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia
| | - Kaylene J Simpson
- Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia
| | - Andreas Hofmann
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia; Griffith Institute for Drug Discovery, Griffith University, Don Young Road, Nathan, Queensland, Australia
| | - Abdul Jabbar
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia.
| | - Robin B Gasser
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, Victoria, Australia.
| |
Collapse
|
23
|
Nathan M, Wiley A, Crawford S, Zhou E, Sullivan KA, Camuso J, Joffe H. 0825 FEMALE REPRODUCTIVE HORMONES AND HOT FLASHES IN PERIMENOPAUSAL SLEEP DISRUPTION. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
24
|
Kawwass J, Kulkarni A, Hipp H, Crawford S, Kissin D, Jamieson D. Assisted reproductive technology cycle and obstetric outcomes among underweight and overweight women. Fertil Steril 2016. [DOI: 10.1016/j.fertnstert.2016.07.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
25
|
Kawwass J, Crawford S, Hipp H, Boulet S, Kissin D, Jamieson D. Embryo donation: national trends and outcomes, 2000-2013. Fertil Steril 2016. [DOI: 10.1016/j.fertnstert.2016.07.907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
26
|
Preston S, Luo J, Zhang Y, Jabbar A, Crawford S, Baell J, Hofmann A, Hu M, Zhou HB, Gasser RB. Selenophene and thiophene-core estrogen receptor ligands that inhibit motility and development of parasitic stages of Haemonchus contortus. Parasit Vectors 2016; 9:346. [PMID: 27306029 PMCID: PMC4910235 DOI: 10.1186/s13071-016-1612-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2016] [Accepted: 05/27/2016] [Indexed: 12/17/2022] Open
Abstract
Background Parasitic worms represent a substantial disease burden in animals and humans worldwide. The control of parasitic roundworms (nematodes) relies heavily on the use of anthelmintic drugs. However, widespread drug resistance in nematodes seriously compromises the effectiveness of many anthelmintics around the world. Thus, there is a need to discover new drugs, with unique modes of action, against parasites. Methods Here, we synthesised and tested 74 selective estrogen receptor modulators (SERMs) for in vitro-activity on parasitic larvae of Haemonchus contortus (barber’s pole worm), one of the most important nematode pathogens of small ruminants (including sheep and goats) and a key representative of one of the largest groups of parasitic nematodes (the Strongylida) of animals. We also studied the morphology of treated and untreated larvae using scanning electron microscopy (SEM), and assessed the agonistic/antagonistic activity of SERMs in a human embryonic kidney cell line using a luciferase reporter assay system. Results We identified three SERMs (one selenophene and two thiophene-core compounds) with potent inhibitory activities (at 3–25 μM) on the motility and development of parasitic stages of H. contortus. An SEM examination of treated H. contortus revealed considerable damage to the cuticle of fourth- but not exsheathed, third-stage larvae; this damage appeared to be consistent with that observed upon treatment with monepantel but not moxidectin (control compounds). Conclusion The potency of the three SERMs compared favourably with commercially available anthelmintics, such that they warrant further assessment as nematocides. Future studies could focus on assessing the selectivity of these SERMs to parasites, characterising their target(s) and/or designing analogs that are parasite-specific. Electronic supplementary material The online version of this article (doi:10.1186/s13071-016-1612-4) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Sarah Preston
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia
| | - Junjie Luo
- Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430072, China
| | - Yuezhou Zhang
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.,Medicinal Chemistry, Monash University Institute of Pharmaceutical Sciences (MIPS), Monash University, Parkville, VIC, 3052, Australia.,State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, 430070, China
| | - Abdul Jabbar
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia
| | - Simon Crawford
- School of Biosciences, The University of Melbourne, Parkville, VIC, 3010, Australia
| | - Jonathan Baell
- Medicinal Chemistry, Monash University Institute of Pharmaceutical Sciences (MIPS), Monash University, Parkville, VIC, 3052, Australia
| | - Andreas Hofmann
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia.,Structural Chemistry Program, Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia
| | - Min Hu
- State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, 430070, China
| | - Hai-Bing Zhou
- Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430072, China.
| | - Robin B Gasser
- Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, Parkville, VIC, 3010, Australia. .,Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Wuhan University School of Pharmaceutical Sciences, Wuhan, 430072, China.
| |
Collapse
|
27
|
Xu M, Wei J, Tobias R, Dick J, Crawford S, Swanson J, Pankuch M. SU-F-T-436: A Method to Evaluate Dosimetric Properties of SFGRT in Eclipse TPS. Med Phys 2016. [DOI: 10.1118/1.4956621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
28
|
McHugh E, Batinovic S, Hanssen E, McMillan PJ, Kenny S, Griffin MD, Crawford S, Trenholme KR, Gardiner DL, Dixon MWA, Tilley L. A repeat sequence domain of the ring-exported protein-1 of Plasmodium falciparum controls export machinery architecture and virulence protein trafficking. Mol Microbiol 2015; 98:1101-14. [PMID: 26304012 PMCID: PMC4987487 DOI: 10.1111/mmi.13201] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/23/2015] [Indexed: 11/30/2022]
Abstract
The malaria parasite Plasmodium falciparum dramatically remodels its host red blood cell to enhance its own survival, using a secretory membrane system that it establishes outside its own cell. Cisternal organelles, called Maurer's clefts, act as a staging point for the forward trafficking of virulence proteins to the red blood cell (RBC) membrane. The Ring-EXported Protein-1 (REX1) is a Maurer's cleft resident protein. We show that inducible knockdown of REX1 causes stacking of Maurer's cleft cisternae without disrupting the organization of the knob-associated histidine-rich protein at the RBC membrane. Genetic dissection of the REX1 sequence shows that loss of a repeat sequence domain results in the formation of giant Maurer's cleft stacks. The stacked Maurer's clefts are decorated with tether-like structures and retain the ability to dock onto the RBC membrane skeleton. The REX1 mutant parasites show deficient export of the major virulence protein, PfEMP1, to the red blood cell surface and markedly reduced binding to the endothelial cell receptor, CD36. REX1 is predicted to form a largely α-helical structure, with a repetitive charge pattern in the repeat sequence domain, providing potential insights into the role of REX1 in Maurer's cleft sculpting.
Collapse
Affiliation(s)
- Emma McHugh
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Steven Batinovic
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Eric Hanssen
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
- Advanced Microscopy Facility, University of Melbourne, Parkville, VIC 3010, Australia
| | - Paul J. McMillan
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
- Biological Optical Microscopy Platform, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia
| | - Shannon Kenny
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Michael D.W. Griffin
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Simon Crawford
- School of BioSciences, University of Melbourne, Parkville, VIC 3010, Australia
| | - Katharine R. Trenholme
- Infectious Diseases Division, Queensland Institute of Medical Research, 300 Herston Rd, Herston, QLD 4006, Australia
| | - Donald L. Gardiner
- Infectious Diseases Division, Queensland Institute of Medical Research, 300 Herston Rd, Herston, QLD 4006, Australia
| | - Matthew W. A. Dixon
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
| | - Leann Tilley
- Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, VIC 3010, Australia
| |
Collapse
|
29
|
Crawford S. On the origins of autism: The Quantitative Threshold Exposure hypothesis. Med Hypotheses 2015; 85:798-806. [PMID: 26481157 DOI: 10.1016/j.mehy.2015.10.006] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2015] [Revised: 09/21/2015] [Accepted: 10/08/2015] [Indexed: 12/27/2022]
Abstract
The Quantitative Threshold Exposure (QTE) hypothesis is a multifactorial threshold model that accounts for the cumulative effects of risk factor exposure in both the causation of autism spectrum disorder (ASD) and its dramatic increase over the past 30 years. The QTE hypothesis proposes that ASD is triggered by the cumulative effects of high-level exposure to endogenous and environmental factors that act as antigens to impair normal immune system (IS) and associated central nervous system (CNS) functions during critical developmental stages. The quantitative threshold parameters that comprise a cumulative risk for the development of ASD are identified by the assessment of documented epidemiological factors that, in sum, determine the likelihood that ASD will occur as a result of their effects on critically integrated IS and CNS pathways active during prenatal, neo-natal and early childhood brain maturation. The model proposes an explanation for the relationship between critical developmental stages of brain/immune system development in conjunction with the quantitative effects of genetic and environmental risk factors that may interface with these critical developmental windows. This model may be useful even when the individual contributions of specific risk factors cannot be quantified, as it proposes that the combined quantitative level of exposure to risk factors for ASD rather than exposure to any one risk factor per se defines threshold occurrence rates.
Collapse
Affiliation(s)
- S Crawford
- Department of Biology, Southern Connecticut State University, 501 Crescent Street, New Haven, CT 06515, United States.
| |
Collapse
|
30
|
Leonard RCF, Mansi JL, Keerie C, Yellowlees A, Crawford S, Benstead K, Matthew R, Adamson D, Chan S, Grieve R. A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor ('SPROG' trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN. Ann Oncol 2015; 26:2437-41. [PMID: 26416895 DOI: 10.1093/annonc/mdv389] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2015] [Accepted: 09/14/2015] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Guidelines on the use of haematopoietic colony-stimulating factors for patients having adjuvant chemotherapy for breast cancer are designed to minimise the risk of neutropaenic infection (Smith TJ, Khatcheressian J, Lyman GH et al. Update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 2006; 3: 187-205; Aapro MS, Bohlius J, Cameron DA et al. Effect of primary prophylactic G-CSF use on systemic therapy administration for elderly breast cancer patients. Breast Cancer Res Treat 2011; 47: 8-32; Carlson RW, Allred DC, Anderson BO et al. Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2009; 7: 122-192). Non-randomised data suggest that the achievement of planned dose intensity (DI) may have an important effect on survival. This trial compared the effects of granulocyte colony-stimulating factor, GCSF, against standard management following a first neutropaenic event (NE) in achieving planned DI. PATIENTS AND METHODS Adult patients receiving adjuvant or neoadjuvant chemotherapy were randomised following a first NE, defined as hospitalisation due to neutropaenic fever, an absolute neutrophil count (ANC) ≤1.5 × 10(9)/l requiring treatment delay or dose reduction of 15% or more of planned dose. The study was initially planned to enrol 816 patients to detect a difference of 10%. This was difficult to achieve in the timeframe and the trial size was amended. Thus, 407 patients were randomly assigned to filgrastim for 7 days or pegfilgrastim versus standard care. The amended study was designed to have 80% power to detect an absolute difference of 14% of planned DI between the two groups. RESULTS Most regimens were anthracycline-based many of which included a sequential taxane and/or were in clinical trials. Around 82.7% had an NE in the first three cycles. A total of 401 had calculable relative dose intensity (RDI) data. A target of 85% planned RDI was achieved in only 50% of patients in the control arm compared with 75% in the GCSF arm (P < 0.0001). A secondary end point revealed a reduction in post-randomisation NEs, 65.7% controls versus 18.2% with GCSF. CONCLUSIONS Secondary intervention with GCSF showed a statistically significant improvement in the achievement of adequate RDI in non-intensive regimens. This may have important clinical implications for outcome.
Collapse
Affiliation(s)
- R C F Leonard
- Department of Surgery and Cancer, Imperial College, London
| | - J L Mansi
- Department of Medical Oncology, Guy's and St Thomas' Hospital and King's College London Biomedical Research Centre, London
| | - C Keerie
- Quantics Consulting Ltd, Edinburgh
| | | | - S Crawford
- Scottish Clinical Trials Research Unit, NHS National Services Scotland, Edinburgh
| | - K Benstead
- Gloucestershire Centre for Clinical Oncology, Cheltenham General Hospital, Cheltenham
| | - R Matthew
- Oncology Department, Northampton General Hospital NHS Trust, Northampton
| | - D Adamson
- Ninewells Hospital and Medical School, Dundee
| | - S Chan
- Department of Clinical Oncology, Nottingham City Hospital, Nottingham
| | - R Grieve
- Arden Cancer Centre, University Hospital, Coventry, UK
| | | |
Collapse
|
31
|
Todkill M, Tyson A, Habel P, Moss P, Rossteuscher K, Didlick J, Crawford S, Freeman H, Martin SJ. P13.08 Act testing month: promoting testing and increasing cross sector collaboration. Br J Vener Dis 2015. [DOI: 10.1136/sextrans-2015-052270.506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
32
|
Sunderam S, Kissin D, Crawford S, Folger S, Jamieson D, Warner L, Barfield W. Overview of 2012 U.S. assisted reproductive technology (ART) treatment outcomes and contribution to multiple birth and preterm infants. Fertil Steril 2015. [DOI: 10.1016/j.fertnstert.2015.07.442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
33
|
Kissin D, Crawford S, Boulet S, Kulkarni A, Toner J, Van Voorhis B, Jamieson D. Trends of assisted reproductive technology (ART) treatment practices and outcomes, United States, 1996-2013. Fertil Steril 2015. [DOI: 10.1016/j.fertnstert.2015.07.682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
34
|
Scott-Van Zeeland AA, Bloss CS, Tewhey R, Bansal V, Torkamani A, Libiger O, Duvvuri V, Wineinger N, Galvez L, Darst BF, Smith EN, Carson A, Pham P, Phillips T, Villarasa N, Tisch R, Zhang G, Levy S, Murray S, Chen W, Srinivasan S, Berenson G, Brandt H, Crawford S, Crow S, Fichter MM, Halmi KA, Johnson C, Kaplan AS, La Via M, Mitchell JE, Strober M, Rotondo A, Treasure J, Woodside DB, Bulik CM, Keel P, Klump KL, Lilenfeld L, Plotnicov K, Topol EJ, Shih PB, Magistretti P, Bergen AW, Berrettini W, Kaye W, Schork NJ. Evidence for the role of EPHX2 gene variants in anorexia nervosa. Mol Psychiatry 2014; 19:724-32. [PMID: 23999524 PMCID: PMC3852189 DOI: 10.1038/mp.2013.91] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2013] [Revised: 06/19/2013] [Accepted: 06/24/2013] [Indexed: 01/08/2023]
Abstract
Anorexia nervosa (AN) and related eating disorders are complex, multifactorial neuropsychiatric conditions with likely rare and common genetic and environmental determinants. To identify genetic variants associated with AN, we pursued a series of sequencing and genotyping studies focusing on the coding regions and upstream sequence of 152 candidate genes in a total of 1205 AN cases and 1948 controls. We identified individual variant associations in the Estrogen Receptor-ß (ESR2) gene, as well as a set of rare and common variants in the Epoxide Hydrolase 2 (EPHX2) gene, in an initial sequencing study of 261 early-onset severe AN cases and 73 controls (P=0.0004). The association of EPHX2 variants was further delineated in: (1) a pooling-based replication study involving an additional 500 AN patients and 500 controls (replication set P=0.00000016); (2) single-locus studies in a cohort of 386 previously genotyped broadly defined AN cases and 295 female population controls from the Bogalusa Heart Study (BHS) and a cohort of 58 individuals with self-reported eating disturbances and 851 controls (combined smallest single locus P<0.01). As EPHX2 is known to influence cholesterol metabolism, and AN is often associated with elevated cholesterol levels, we also investigated the association of EPHX2 variants and longitudinal body mass index (BMI) and cholesterol in BHS female and male subjects (N=229) and found evidence for a modifying effect of a subset of variants on the relationship between cholesterol and BMI (P<0.01). These findings suggest a novel association of gene variants within EPHX2 to susceptibility to AN and provide a foundation for future study of this important yet poorly understood condition.
Collapse
Affiliation(s)
- A A Scott-Van Zeeland
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - C S Bloss
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - R Tewhey
- Scripps Health, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | - V Bansal
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - A Torkamani
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | - O Libiger
- The Scripps Translational Science Institute, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | - V Duvvuri
- Department of Pediatrics, The University of California, San Diego, La Jolla, CA, USA
| | - N Wineinger
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - L Galvez
- The Scripps Translational Science Institute, La Jolla, CA, USA
| | - B F Darst
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - E N Smith
- Department of Pediatrics, The University of California, San Diego, La Jolla, CA, USA
| | - A Carson
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - P Pham
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - T Phillips
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - N Villarasa
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - R Tisch
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - G Zhang
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA
| | - S Levy
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | - S Murray
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | - W Chen
- Department of Epidemiology, Tulane University, New Orleans, LA, USA
| | - S Srinivasan
- Department of Epidemiology, Tulane University, New Orleans, LA, USA
| | - G Berenson
- Department of Epidemiology, Tulane University, New Orleans, LA, USA
| | - H Brandt
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - S Crawford
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - S Crow
- Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA
| | - M M Fichter
- Roseneck Hospital for Behavioral Medicine, Prien, Germany
| | - K A Halmi
- Eating Disorder Research Program Weill Cornell Medical College, White Plains, NY, USA
| | - C Johnson
- Eating Recovery Center, Denver, CO, USA
| | - A S Kaplan
- Center for Addiction and Mental Health, Toronto, ON, Canada,Department of Psychiatry, Toronto General Hospital, University Health Network, Toronto, ON, Canada,Department of Psychiatry, University of Toronto, Toronto, ON, Canada
| | - M La Via
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - J E Mitchell
- Neuropsychiatric Research Institute, Fargo, ND, USA,Department of Clinical Neuroscience, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND, USA
| | - M Strober
- Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA
| | - A Rotondo
- Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Pisa, Italy
| | - J Treasure
- Department of Academic Psychiatry, Bermondsey Wing Guys Hospital, University of London, London, UK
| | - D B Woodside
- Department of Psychiatry, Toronto General Hospital, University Health Network, Toronto, ON, Canada,Department of Psychiatry, University of Toronto, Toronto, ON, Canada,Department of Psychology, Florida State University, Tallahassee, FL, USA
| | - C M Bulik
- Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA,Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - P Keel
- Department of Psychology, Florida State University, Tallahassee, FL, USA
| | - K L Klump
- Department of Psychology, Michigan State University, East Lansing, MI, USA
| | - L Lilenfeld
- Clinical Psychology Program, American School of Professional Psychology at Argosy University, Washington, DC, USA
| | - K Plotnicov
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
| | - E J Topol
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
| | - P B Shih
- Department of Pediatrics, The University of California, San Diego, La Jolla, CA, USA
| | - P Magistretti
- Laboratory of Neuroenergetics and Cellular Dynamics, The University of Lausanne, Lausanne, Switzerland
| | - A W Bergen
- Center for Health Sciences, SRI International, Menlo Park, CA, USA
| | - W Berrettini
- Department of Psychiatry, The University of Pennsylvania, Philadelphia, PA, USA
| | - W Kaye
- Department of Pediatrics, The University of California, San Diego, La Jolla, CA, USA
| | - N J Schork
- The Scripps Translational Science Institute, La Jolla, CA, USA,Scripps Health, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA,Department of Molecular and Experimental Medicine, The Scripps Research Institute, 3344 N Torrey Pines Court, Room 306, La Jolla, CA 92037, USA. E-mail:
| |
Collapse
|
35
|
Tarbet EB, Hamilton S, Vollmer AH, Luttick A, Ng WC, Pryor M, Hurst BL, Crawford S, Smee DF, Tucker SP. A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses. J Antimicrob Chemother 2014; 69:2164-74. [PMID: 24777908 DOI: 10.1093/jac/dku127] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
OBJECTIVES Emerging drug resistance to antiviral therapies is an increasing challenge for the treatment of influenza virus infections. One new antiviral compound, BTA938, a dimeric derivative of the viral neuraminidase inhibitor zanamivir, contains a 14-carbon linker bridging two zanamivir moieties. In these studies, we evaluated antiviral efficacy in cell cultures infected with influenza virus and in mouse models of lethal influenza using H1N1pdm09, H3N2 and oseltamivir-resistant (H275Y) viruses. METHODS In vitro activity was evaluated against 22 strains of influenza virus. Additionally, in vivo studies compared the efficacy of BTA938 or zanamivir after intranasal treatment. We also tested the hypothesis of a dual mode of action for BTA938 using scanning electron microscopy (SEM). RESULTS BTA938 inhibited the viruses at nanomolar concentrations in vitro with a median 50% effective concentration value of 0.5 nM. In mouse models, the dimer provided ∼10-fold greater protection than zanamivir. The data also showed that a single low dose (3 mg/kg) protected 100% of mice from an otherwise lethal oseltamivir-resistant (H275Y) influenza virus infection. Remarkably, a single prophylactic treatment (10 mg/kg) administered 7 days before the challenge protected 70% of mice and when administered 1 or 3 days before the challenge it protected 90% of mice. Additionally, SEM provides evidence that the increased antiviral potency may be mediated by an enhanced aggregation of virus on the cell surface. CONCLUSIONS In vitro and in vivo experiments showed the high antiviral activity of BTA938 for the treatment of influenza virus infections. Moreover, we demonstrated that a single dose of BTA938 is sufficient for prophylactic and therapeutic protection in mouse models.
Collapse
Affiliation(s)
- E Bart Tarbet
- Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA
| | | | - Almut H Vollmer
- Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA
| | | | - Wy Ching Ng
- Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia
| | | | - Brett L Hurst
- Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA
| | - Simon Crawford
- School of Botany, University of Melbourne, Parkville, Australia
| | - Donald F Smee
- Institute for Antiviral Research, Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA
| | | |
Collapse
|
36
|
Kan A, Tan YH, Angrisano F, Hanssen E, Rogers KL, Whitehead L, Mollard VP, Cozijnsen A, Delves MJ, Crawford S, Sinden RE, McFadden GI, Leckie C, Bailey J, Baum J. Quantitative analysis of Plasmodium ookinete motion in three dimensions suggests a critical role for cell shape in the biomechanics of malaria parasite gliding motility. Cell Microbiol 2014; 16:734-50. [PMID: 24612056 PMCID: PMC4286792 DOI: 10.1111/cmi.12283] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2013] [Revised: 01/22/2014] [Accepted: 02/13/2014] [Indexed: 11/28/2022]
Abstract
Motility is a fundamental part of cellular life and survival, including for Plasmodium parasites--single-celled protozoan pathogens responsible for human malaria. The motile life cycle forms achieve motility, called gliding, via the activity of an internal actomyosin motor. Although gliding is based on the well-studied system of actin and myosin, its core biomechanics are not completely understood. Currently accepted models suggest it results from a specifically organized cellular motor that produces a rearward directional force. When linked to surface-bound adhesins, this force is passaged to the cell posterior, propelling the parasite forwards. Gliding motility is observed in all three life cycle stages of Plasmodium: sporozoites, merozoites and ookinetes. However, it is only the ookinetes--formed inside the midgut of infected mosquitoes--that display continuous gliding without the necessity of host cell entry. This makes them ideal candidates for invasion-free biomechanical analysis. Here we apply a plate-based imaging approach to study ookinete motion in three-dimensional (3D) space to understand Plasmodium cell motility and how movement facilitates midgut colonization. Using single-cell tracking and numerical analysis of parasite motion in 3D, our analysis demonstrates that ookinetes move with a conserved left-handed helical trajectory. Investigation of cell morphology suggests this trajectory may be based on the ookinete subpellicular cytoskeleton, with complementary whole and subcellular electron microscopy showing that, like their motion paths, ookinetes share a conserved left-handed corkscrew shape and underlying twisted microtubular architecture. Through comparisons of 3D movement between wild-type ookinetes and a cytoskeleton-knockout mutant we demonstrate that perturbation of cell shape changes motion from helical to broadly linear. Therefore, while the precise linkages between cellular architecture and actomyosin motor organization remain unknown, our analysis suggests that the molecular basis of cell shape may, in addition to motor force, be a key adaptive strategy for malaria parasite dissemination and, as such, transmission.
Collapse
Affiliation(s)
- Andrey Kan
- Victoria Research Laboratory, National ICT Australia (NICTA), Department of Computing and Information Systems, University of Melbourne, Melbourne, Vic., 3010, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Brooks BL, Kadoura B, Turley B, Crawford S, Mikrogianakis A, Barlow KM. Perception of Recovery After Pediatric Mild Traumatic Brain Injury Is Influenced by the "Good Old Days" Bias: Tangible Implications for Clinical Practice and Outcomes Research. Arch Clin Neuropsychol 2013; 29:186-93. [DOI: 10.1093/arclin/act083] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Kawwass J, Monsour M, Crawford S, Kissin D, Session D, Jamieson D. Donor oocyte: trends and predictors of good perinatal outcome. Fertil Steril 2013. [DOI: 10.1016/j.fertnstert.2013.07.327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
39
|
Mitra R, Crawford S, Barton AF, Briggs S, Orbell JD. A benign approach to the preparation of freshwater bryozoan statoblasts for scanning electron microscopy (SEM) imaging. New Zealand Journal of Zoology 2013. [DOI: 10.1080/03014223.2012.672436] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
40
|
Thornhill A, Dibouni ZA, Shah T, Wheat S, Teitelbaum M, Walker M, Bissonette F, Yuzpe AL, Leveille MC, Gysler M, Johnson M, Sprague A, Villena JG, Aparicio JL, Gimenez J, Ten J, Perez RB, Scholten I, Chambers GM, van Loendersloot L, van der Veen F, Repping S, Gianotten J, Hompes PGA, Ledger W, Mol BWJ, Dior UP, Laufer N, Granovsky-Grisaru S, Yagel S, Yaffe H, Gielchinsky Y, Nelen WLDM, Huppelschoten AG, Verkerk EW, Adang EMM, Kremer JAM, Davies M, Rumbold A, Marino J, Willson K, Moore V, Giles L, Shebl O, Ebner T, Tews G, Haas D, Oppelt P, Mayer RB, Sanges F, Maggiulli R, Albricci L, Romano S, Scarica C, Schimberni M, Giallonardo A, Vettraino G, Ubaldi F, Rienzi L, Figueira RCS, Braga DPAF, Setti AS, Iaconelli A, Borges E, Obrado EC, Barredo DR, Navarro LL, Rodriguez AV, Rague PNB, Lletget BC, Padro RT, Oron G, Sokal-Arnon T, Zeadna A, Son WY, Holzer H, Tulandi T, Nakamura Y, Hattori H, Sato Y, Kuchiki M, Sakamoto E, Doshida M, Toya M, Kyono K, Nakajo Y, Nakamura Y, Hirata K, Doshida M, Toya M, Kyono K, Xin ZM, Zhu H, Sun YP, Jin HX, Song WY, Rodriguez A, Poisot F, Rodriguez F, Coll O, Vassena R, Vernaeve V, Ye Y, Wang L, Wang N, Le F, Jin F, Zheng Y, Jin F, Lou Y, Le F, Pan PP, Wang N, Wang LY, Hu CX, Liu SY, Zheng YM, Li LJ, Liu XZ, Xu XR, Huang HF, Jin F, Lin SL, Li M, Lian Y, Chen LX, Liu P, Kawwass JF, Crawford S, Kissin DM, Session DR, Boulet S, Jamieson DJ. Quality and safety of ART therapies. Hum Reprod 2013. [DOI: 10.1093/humrep/det219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Crawford S, Garrard J. A combined impact-process evaluation of a program promoting active transport to school: understanding the factors that shaped program effectiveness. J Environ Public Health 2013; 2013:816961. [PMID: 23606865 PMCID: PMC3628214 DOI: 10.1155/2013/816961] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 11/28/2012] [Revised: 02/12/2013] [Accepted: 02/13/2013] [Indexed: 11/28/2022]
Abstract
This mixed methods study was a comprehensive impact-process evaluation of the Ride2School program in metropolitan and regional areas in Victoria, Australia. The program aimed to promote transport to school for primary school children. Qualitative and quantitative data were collected at baseline and followup from two primary schools involved in the pilot phase of the program and two matched comparison schools, and a further 13 primary schools that participated in the implementation phase of the program. Classroom surveys, structured and unstructured observations, and interviews with Ride2School program staff were used to evaluate the pilot program. For the 13 schools in the second phase of the program, parents and students completed questionnaires at baseline (N = 889) and followup (N = 761). Based on the quantitative data, there was little evidence of an overall increase in active transport to school across participating schools, although impacts varied among individual schools. Qualitative data in the form of observations, interviews, and focus group discussions with students, school staff, and program staff provided insight into the reasons for variable program impacts. This paper highlights the benefits of undertaking a mixed methods approach to evaluating active transport to school programs that enables both measurement and understanding of program impacts.
Collapse
Affiliation(s)
- S Crawford
- Deakin University, 221 Burwood Highway, Burwood, VIC 3125, Australia.
| | | |
Collapse
|
42
|
Crawford S, Malvy CP, Vauthier C, Bertrand JR, Ramon AL, Winkler J, Burgess L, Laird E, Weaver D, Chantry D, Hernandez JC, Guerrero CA, Acosta O, Granja S, Lee CT, Park MY, Eo EY, Lee JH. Poster session 1. Target identification & validation. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
43
|
Crawford S. A New Paradigm for Cancer Therapy: A Targeted Systemic Preventive/Therapeutic Approach. Ann Oncol 2013. [DOI: 10.1093/annonc/mdt043.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
44
|
Liao L, Bonsignori M, Hwang K, Moody AM, Park R, Crawford S, Chen H, Jeffries TL, Cooper M, Lu X, De R, Karasavvas N, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Tovanabutra S, Pitisuttithum P, Tartaglia J, Sinangil F, Kim J, Michael NL, Tomaras GD, Yang Z, Dai K, Pancera M, Nabel GJ, Mascola JR, Kwong PD, Pinter A, Zolla-Pazner S, Alam MS, Haynes BF. Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2. Retrovirology 2012. [PMCID: PMC3441578 DOI: 10.1186/1742-4690-9-s2-o31] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
45
|
Taubenheim N, Tarlinton DM, Crawford S, Corcoran LM, Hodgkin PD, Nutt SL. High Rate of Antibody Secretion Is not Integral to Plasma Cell Differentiation as Revealed by XBP-1 Deficiency. J I 2012; 189:3328-38. [DOI: 10.4049/jimmunol.1201042] [Citation(s) in RCA: 96] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
|
46
|
Fayez R, AlMuntashery A, Bodie G, Almamar A, Gill R, Raîche I, Mueller C, AlMuntashery A, Fayez R, AlMuntashery A, Moustarah F, Khokhotva M, Anvari M, Kwong J, Elkassem S, Bonrath E, Zevin B, Sockalingam S, Smith C, Smith C, Whitlock K, Gill R, Suri M, Palter V, Wakeam E, Khan R, Martelli V, Malik A, Young P, Daigle C, McCreery G, Seth R, Paskar D, Sudarshan M, Richardson D, Haggar F, Davis V, Rivard J, Agzarian J, Racz J, Winocour J, Zilbert N, Decker C, Neumann K, Gosney J, Wissanji H, Chadi S, Alhabboubi M, Partridge E, Alhabboubi M, Olszewski M, Chan R, Nadler A, Hameed U, Brotherhood H, Menezes A, MacDonald B, Rakovich G, Hilsden R, Merani S, Davis P, Davis P, Cools-Lartigue J, Ojah J, Julien F, Carter D, Pitt D, Banks B, Rudovics A, Ravichandran P, Anantha R, Aad I, Kholdebarin R, Aird L, Wong S, Payne J, Hallet J, Farries L, Raiche I, Botkin C, Morency D, Berger-Richardson D, Isa A, Dupuis I, Schweigert M, Koubi S, Ernjakovic M, Grant K, Cools-Lartigue J, Carrott P, Stafford T, Malthaner R, Sudarshan M, Hanna W, Lee L, Markar S, Razzak R, Bharadwaj S, Ashrafi A, Ouellette D, Fergusson D, Forster A, Boushey R, Porter G, Johnson P, Gomes T, Chan B, Auer R, Moloo H, Mamdani M, Markar S, Al-Omran M, Al-Obaid O, Boushey R, Lim DR, Min BS, Baik SH, Gordon P, Kim NK, Lo A, Pinsk I, Bottoni D, Brown C, Raval M, Cheng H, Wong C, Johnston N, Farrokhyar F, Stephen W, Kelly S, Lindsay L, Forbes S, Knickle C, Bouchard A, Parry N, Leslie K, Ott M, Coughlin S, Gazala S, Gazala S, Donahoe L, Walker K, Li C, Alnasser S, Schweigert M, Schweigert M, Zhuruk A, Hanouf A, Vanounou T, Karanicolas P, Aubin JM, Yeung J, Dumitra S, Simoneau E, Vanounou T, Howe B, Hawel J, Jang JH, Bertens K, Rekman J, Wei A, Dumitra S, Koubi S, Ouellet JF, Wei A, Covelli A, Maniar R, Sun S, Davis V, Brackstone M, Boissonneault R, Kim S, Baliski C, Gazala S, Hameed U, Sudarshan M, Arnaout A, Wedman D, Nostedt M, Hebbard P, Shetty S, Dixon M, Wei A, Dixon M, Kazazian K, Lemke M, Wells B, Musselman R, Zih FSW, Menezes A, Nassif M, Leon-Carlyle M, Wei A, Krotneva S, Bradley N, Trabulsi N, Trabulsi N, Chin-Lenn L, Cheng H, Petrucci A, Sandhu L, Neville A, Lee L, Li C, Yang I, Prabhu KL, Melich G, Knowles S, Richardson D, Borowiec A, Hallet J, Boissonneault R, Kolozsvari N, Hallet J, Tuttle P, VanHouwelingen L, Haggar F, Boulanger-Gobeil C, Chan B, Chan B, Richardson D, Musselman R, Melich G, Phang P, Goldstein L, Wen C, Lebrun A, Chadi S, Roy M, Villeneuve S, AlMuntashery A, Demyttenaere S, Christou N, Court O, Fayez R, Demyttenaere S, Christou N, Court O, Bonrath E, Hagen J, Okrainec A, Sullivan P, Grantcharov T, Sharma A, Karmali S, Birch D, Majumdar S, Wang X, Tuepah R, Klarenbach S, Birch D, Karmali S, Sharma A, Padwal R, Smith C, Haggar F, Moloo H, Poulin E, Martel G, Yelle JD, Mamazza J, Jackson T, Penner T, Pitzul K, Urbach D, Okrainec A, Villeneuve S, Roy M, Fayez R, Demyttenaere S, Christou N, Court O, Roy M, Villeneuve S, AlMuntashery A, Demyttenaere S, Christou N, Court O, Fayez R, Demyttenaere S, Court O, Christou N, Biertho L, Hould FS, Lebel S, Lescelleur O, Marceau S, Marceau P, Biron S, Grantcharov T, Sharma A, Yusuf S, Okrainec A, Pitzul K, Urbach D, Jackson T, Lindsay D, Sullivan P, Smith L, Zevin B, Dedy N, Grantcharov T, Bonrath E, Aggarwal R, Grantcharov T, Cassin S, Crawford S, Pitzul K, Khan A, Hawa R, Jackson T, Okrainec A, Brar B, Mamazza J, Raîche I, Yelle JD, Haggar F, Moloo H, Brar B, Haggar F, Dent R, Mamazza J, Raîche I, Moloo H, Gill R, Ali T, Shi X, Birch D, Karmali S, Whitlock K, Shi X, Sarkhosh K, Birch D, Karmali S, Turner J, Nation P, Wizzard P, Brubaker P, Gisalet D, Wales P, Grantcharov T, Tien H, Spencer F, Brenneman F, Kowal J, Wiseman S, Fraser S, Vedel I, Deban M, Holcroft C, Monette M, Monette J, Bergman S, Bell C, Stukel T, Urbach D, Mueller T, Lucykx V, Lukowski C, Compston C, Churchill T, Khadaroo R, Grantcharov T, Vogt K, Dubois L, Gray D, Ananth A, Tai LH, Lam T, Falls T, Souza C, Bell J, Auer R, Crawford S, Parry N, Leslie K, Alhabboubi M, St-Louis E, Deckelbaum D, Razek T, Feldman L, Khwaja K, Porter G, Johnson P, Boushey R, Moloo H, Raiche I, Mamazza J, Schiller D, Eurich D, Sawyer M, Vergis A, Unger B, Hardy K, Andrew C, Gillman L, Park J, Prodger J, Kelly W, Kelly S, Prodger D, Ewara E, Martin J, Sarma S, Chu M, Schlachta C, Zaric G, Al-Ali K, Briggs K, George R, Murnaghan M, Leung A, Regehr G, Moulton CA, Mahmud S, Metcalfe J, McKay A, Park J, Hochman D, Burkle F, Redmond A, McQueen K, Desrosiers E, Gilbert A, Leslie K, Ott M, Sudarshan M, Jessula S, Alburakan A, Deckelbaum D, Razek T, Iqbal S, Khwaja K, Aikins C, Sudarshan M, Deckelbaum D, Iqbal S, Khwaja K, Razek T, Roberts N, Moulton CA, Murnaghan M, Cil T, Marshall J, Pederson K, Erichsen S, White J, Aarts MA, Okrainec A, Victor J, Pearsall E, McLeod R, Jackson T, Okrainec A, Penner T, Urbach D, Karimuddin A, Hall C, Bawan S, Malik S, Hayashi A, Gill R, McAlister C, Zhang N, DesRosiers E, Mills A, Crozier M, Lee L, Maxwell J, Partridge E, Chad S, Steigerwald S, Mapiour D, Roberts D, MacPherson C, Donahoe L, Mercer D, Hopman W, Latulippe JF, Knowles S, Moffat B, Parry N, Leslie K, Switzer N, Khadaroo R, Tul Y, Widder S, Molinari M, Levy A, Johnson P, Bailey J, Molinari M, Hayden J, Johnson P, Benlolo S, Marcus V, Ferri L, Finley R, Anderson D, Gagné JP, Chan S, Wong S, Li J, Michael A, Choi D, Liu E, Hoogenes J, Dath D, Aubin JM, Mew D, McConnell Y, Classen D, Kanthan S, Croome K, Kovacs M, Lazo-Langner A, Hernandez-Alejandro R, Vogt K, Crawford S, Parry N, Leslie K, Khoshgoo N, Iwasiow B, Keijzer R, Brown C, Isa D, Pace D, Widder S, Tul Y, Primrose M, Hudson D, Khadaroo R, Lauzier F, Mailloux O, Trottier V, ARchambault P, Zarychanski R, Turgeon A, Mailloux O, Hardy P, Muirhead R, Masters J, Haggar F, Poulin HME, Martel G, Mamazza J, Milbrandt C, Keijzer R, Sideris L, Grenier-Vallée P, Latulippe JF, Dubé P, Kurashima Y, Kaneva P, Feldman L, Fried G, Vassiliou M, Kwan AL, Fraser S, Solymosi N, Rauh N, Dubecz A, Renz M, Ofner D, Stein H, Borgaonkar M, Crystal P, Easson A, Escallon J, Reedijk M, Cil T, Leong W, McCready D, Clifton J, Mayo J, Finley R, Noreau-Nguyen M, Mulder D, Ferri L, Markar S, Hong J, Low D, Maslow A, Davignon K, Ng T, Tan L, Aruranian J, Kosa S, Ferri L, Murphy G, Allison F, Moshonov H, Darling G, Waddell T, De Perrot M, Cypel M, Yasufuku K, Keshavjee S, Paul N, Pierre A, Darling G, Pedneault C, Marcus V, Mulder D, Ferri L, Low D, Roa W, Löbenberg R, McEwan S, Bédard E, Louie B, Farivar A, McHugh S, Aye R, Tan-Tam C, De Vera M, Bond R, Ong S, Johal B, Schellenberg D, Po M, Nissar S, Lund C, Ahmadi S, Wakil N, Rakovich G, Beauchamps G, Preston S, Baker C, Low D, Campbell G, Malthaner R, Bethune D, Henteleff H, Johnston M, Buduhan G, Coughlin HE, Roth L, Bhandari M, Malthaner R, Johnson J, Kutsogiannis J, Bédard E, Rammohan K, Stewart K, Bédard E, Buduhan G, Gruchy J, Xu Z, Buduhan G, Ferri L, Mulder D, Ncuti A, Neville A, Kaneva P, Watson D, Vassiliou M, Carli F, Feldman L, Av R, Mayrand S, Franco E, Ferri L, Dubecz A, Renz M, Stadlhuber R, Ofner D, Stein H, Renz M, Dubecz A, Solymosi N, Thumfart L, Ofner D, Stein H, Croome K, Leeper R, Hernandez R, Livingstone S, Sapp J, Woodhall D, Alwayn I, Bergman S, Lam-McCulloch J, Balaa F, Jayaraman S, Quan D, Wei A, Guyatt G, Rekman J, Fairfull-Smith R, Mimeault R, Balaa F, Martel G, Boehnert M, Bazerbachi F, Knaak J, Selzner N, McGilvray I, Rotstein O, Adeyi O, Levy G, Keshavjee S, Grant D, Selzner M, Khalil JA, Jamal M, Chaudhury P, Zogopoulos G, Petrakos P, Tchervenkov J, Barkun J, Jamal M, Hassanain M, Chaudhury P, Wong S, Salman A, Tran T, Metrakos P, Groeschl R, Geller D, Marsh J, Gamblin T, Croome K, Croome K, Quan D, Hernandez R, Kim P, Greig PD, Gallinger S, Moulton CA, Wei A, Fischer S, Cleary S, Vogt K, Hernandez-Alejandro R, Gray D, Aubin J, Fairfull-Smith J, Mimeault R, Balaa F, Martel G, Devitt K, Ramjaun A, Gallingher S, Alabbad S, Constantinos D, Hassanein M, Barkun J, Metrakos P, Paraskevas S, Chaudhury P, Tchervenkov J, Borgaonkar M, Tanyingoh D, Dixon E, Kaplan G, Myers R, Howard T, Sutherland F, Zyromski N, Ball C, Coburn N, Moulton CA, Cleary S, Law C, Greig P, Steven G, Baxter N, Fitch M, Wright F, Hochman D, Wirtzfeld D, McKay A, Yaffe C, Yip B, Silverman R, Park J, McConnell Y, Temple W, Mack L, Schiller D, Bathe O, Sawyer M, Scott L, Vandenberg T, Perera F, Potvin K, Chambers A, Loungnarath R, DeBroux É, Lavertu S, Donath D, Ayoub JP, Tehfé M, Richard C, Cornacchi S, Heller B, Farrokhyar F, Babra M, Lovrics P, Liberto C, Ghosh S, McLean R, Schiller D, Jackson T, Okrainec A, Penner T, Urbach D, Dumitra S, Duplisea J, Wexler S, Seely J, Smylie J, Knight K, Robertson S, Watters J, Zhang T, Arneout A, Hochman D, Wirtzfeld D, McKay A, Yip B, Yaffe C, Silverman R, Park J, Baxter N, Yun L, Rakovitch E, Wright F, Warner E, McCready D, Hodgson N, Quan M, Natarajan B, Govindarajan V, Thomas P, Loggie B, Brar S, Mahar A, Law C, Coburn N, Devitt K, Wiebe M, Bathe O, McLeod R, Baxter N, Gagliardi A, Kennedy E, Urbach D, Brar S, Mahar A, Law C, Coburn N, Zih F, Rosario C, Dennis J, Gingras AC, Swallow C, Ko YJ, Rowsell C, Law C, Saskin R, Quan ML, Xie M, McLaughlin K, Marginean C, Moyana T, Moloo H, Boushey R, Auer R, Razik R, Haase E, Mathieson A, Smith A, Swallow C, Barnes A, Scheer A, Moloo H, Boushey R, Sabri E, Auer R, Reidel K, Trabulsi N, Meterissian S, Tamblyn R, Mayo N, Meguerditchian A, Brown J, Hamm J, Phang P, Raval M, Brown C, Devitt K, Wiebe M, Bathe O, McLeod R, Taylor B, Urbach D, Reidel K, Mayo N, Tamblyn R, Meguerditchian A, Hamm J, Wiseman S, Patakfalvi L, Nassif M, Turcotte R, Nichols A, Meguerditchian A, Riedel K, Winslade N, Grégoire JP, Meterissian S, Abrahamovicz M, Megueerditchian A, Pasieka J, McMillan C, Lipa J, Snell L, Sudarshan M, Dumitra S, Duplisea J, Wexler S, Meterissian S, Tomlinson G, Kennedy E, Wei A, Baxter N, Urbach D, Liberman A, Charlebois P, Stein B, Ncuti A, Vassiliou M, Fried G, Feldman L, Capretti G, Power A, Liberman A, Charlebois P, Stein B, Kaneva P, Carli F, Fried G, Feldman L, Carli F, Charlebois P, Stein B, Liberman A, Kaneva P, Augustin B, Gamsa A, Kim DJ, Vassiliou M, Feldman L, Boushey R, Moloo H, Vu L, Chan S, Phang P, Gown A, Jones S, Wiseman S, Jeong DH, Hur H, Baik SH, Kim NK, Faria J, Min BS, Lumb K, Colquhoun P, Porter G, Johnson P, Baxter N, Schmocker S, Huang H, Victor J, Krzyzanowska MK, Brierley J, McLeod R, Kennedy E, Milot H, Desrosiers E, Lebrun A, Drolet S, Bouchard A, Grégoire R, Vuong T, Loungnarath R, DeBroux E, Liberman A, Charlebois P, Stein B, Richard C, Capretti G, Kaneva P, Neville A, Carli F, Liberman S, Charlebois P, Stein B, Vassiliou M, Fried G, Feldman L, Milot H, Drolet S, Bouchard A, Grégoire R, Powell R, Fowler A, Mathieson A, Martin K, Vogt K, Ott M, Pereira G, Einarsdottir K, Moloo H, Boushey R, Mamazza J, Bouchard A, Gagné J, Grégoire R, Thibault C, Bouchard P, Gomes T, Musselman R, Auer R, Moloo H, Mamdani M, Al-Omran M, Boushey R, AlObeed O, Armstrong J. Canadian Surgery Forum1 Is laparoscopic sleeve gastrectomy a reasonable stand-alone procedure for super morbidly obese patients?2 Postoperative monitoring requirements of patients with obstructive sleep apnea undergoing bariatric surgery3 Role of relaparoscopy in the diagnosis and treatment of bariatric complications in the early postoperative period4 Changes of active and total ghrelin, GLP-1 and PYY following restrictive bariatric surgery and their impact on satiety: comparison of sleeve gastrectomy and adjustable gastric banding5 Prioritization and willingness to pay for bariatric surgery: the patient perspective6 Ventral hernia at the time of laparoscopic gastric bypass surgery: Should it be repaired?7 Linear stapled gastrojejunostomy with transverse handsewn enterotomy closure significantly reduces strictures for laparoscopic Roux-en-Y bypass8 Laparoscopic biliopancreatic diversion with duodenal switch as second stage for super super morbidly obese patients. Do all patients benefit?9 Sleeve gastrectomy in the super super morbidly obese (BMI > 60 kg/m2): a Canadian experience10 Laparoscopic gastric bypass for the treatment of refractory idiopathic gastroparesis: a report of 2 cases11 Duodeno-ileal switch as a primary bariatric and metabolic surgical option for the severely obese patient with comorbidities: review of a single-institution case series of duodeno-ileal intestinal bypass12 Management of large paraesophageal hernias in morbidly obese patients with laparoscopic sleeve gastrectomy: a case series13 Early results of the Ontario bariatric surgical program: using the bariatric registry14 Improving access to bariatric surgical care: Is universal health care the answer?15 Early and liberal postoperative exploration can reduce morbidity and mortality in patients undergoing bariatric surgery16 Withdrawn17 Identification and assessment of technical errors in laparoscopic Roux-en-Y gastric bypass18 A valid and reliable tool for assessment of surgical skill in laparoscopic Roux-en-Y gastric bypass19 Psychiatric predictors of presurgery drop-out following suitability assessment for bariatric surgery20 Predictors of outcomes following Roux-en-Y gastric bypass surgery at The Ottawa Hospital21 Prophylactic management of cholelithiasis in bariatric patients: Is routine cholecystectomy warranted?22 Early outcomes of Roux-en-Y gastric bypass in a publicly funded obesity program23 Similar incidence of gastrojejunal anastomotic stricture formation with hand-sewn and 21 mm circular stapler techniques during Roux-en-Y gastric bypass24 (CAGS Basic Science Award) Exogenous glucagon-like peptide-1 improves clinical, morphological and histological outcomes of intestinal adaptation in a distal-intestinal resection piglet model of short bowel syndrome25 (CAGS Clinical Research Award) Development and validation of a comprehensive curriculum to teach an advanced minimally invasive procedure: a randomized controlled trial26 Negative-pressure wound therapy (iVAC) on closed, high-risk incisions following abdominal wall reconstruction27 The impact of seed granting on research in the University of British Columbia Department of Surgery28 Quality of surgical care is inadequate for elderly patients29 Recurrence of inguinal hernia in general and hernia specialty hospitals in Ontario, Canada30 Oncostatin M receptor deficiency results in increased mortality in an intestinal ischemia reperfusion model in mice31 Laparoscopic repair of large paraesophageal hernias with anterior gastropexy: a multicentre trial32 Response to preoperative medical therapy predicts success of laparoscopic splenectomy for immune thrombocytopenic purpura33 Perioperative sepsis, but not hemorrhagic shock, promotes the development of cancer metastases in a murine model34 Measuring the impact of implementing an acute care surgery service on the management of acute biliary disease35 Patient flow and efficiency in an acute care surgery service36 The relationship between treatment factors and postoperative complications after radical surgery for rectal cancer37 Risk of ventral hernia after laparoscopic colon surgery38 Urinary metabolomics as a tool for early detection of Barrett’s and esophageal cancer39 Construct validity of individual and summary performance metrics associated with a computer-based laparo-scopic simulator40 Impact of a city-wide health system reorganization on emergency department visits in hospitals in surrounding communities41 Transcatheter aortic valve implantation for the nonoperative management of aortic stenosis: a cost-effectiveness analysis42 Breast cancer: racial differences in age of onset. A potential confounder in Canadian screening recommendations43 Risk taking in surgery: in and out of the comfort zone44 A tumour board in the office: Track those cancer patients!45 Increased patient BMI is not associated with advanced colon cancer stage or grade on presentation: a retrospective chart review46 Consensus statements regarding the multidisciplinary care of limb amputation patients in disasters or humanitarian emergencies. Report of the 2011 Humanitarian Action Summit Surgical Working Group on amputations following disasters or conflict47 Learning the CanMEDS role of professional: a pilot project of supervised discussion groups addressing the hidden curriculum48 Assessing the changing scope of training in Canadian general surgery programs: expected versus actual experience49 Predicting need for surgical management for massive gastrointestinal hemorrhage50 International health care experience: using CanMEDS to evaluate learning outcomes following a surgical mission in Mampong, Ghana51 The open abdomen: risk factors for mortality and rates of closure52 How surgeons think: an exploration of mental practice in surgical preparation53 The surgery wiki: a novel method for delivery of under-graduate surgical education54 Understanding surgical residents’ postoperative practices before implementing an enhanced recovery after surgery (ERAS) guideline at the University of Toronto55 From laparoscopic transabdominal to posterior retroperitoneal adrenalectomy: a paradigm shift in operative approach56 A retrospective audit of outcomes in patients over the age of 80 undergoing acute care abdominal surgery57 Canadian general surgery residents’ perspectives on work-hour regulations58 Timing of surgical intervention and its outcomes in acute appendicitis59 Preparing surgical trainees to deal with adverse events. An outline of learning issues60 Acute care surgical service: surgeon agreement at the time of handover61 Predicting discharge of elderly patients to prehospitalization residence following emergency general surgery62 Morbidity and mortality after emergency abdominal surgery in octo- and nonagenarians63 The impact of acute abdominal illness and urgent admission to hospital on the living situation of elderly patients64 A comparison of laparoscopic versus open subtotal gastrectomy for antral gastric adenocarcinoma: a North American perspective65 Minimally invasive excision of ectopic mediastinal parathyroid adenomas66 Perioperative outcomes of laparoscopic hernia repair in a tertiary care centre: a single institution’s experience67 Evaluation of a student-run, practical and didactic curriculum for preclerkship medical students68 Joseph Lister: Father of Modern Surgery69 Comparisons of melanoma sentinel lymph node biopsy prediction nomograms in a cohort of Canadian patients70 Local experience with myocutaneous flaps after extensive pelvic surgery71 The treatment of noncirrhotic splanchnic vein thrombosis: Is anticoagulation enough?72 Implementation of an acute care surgery service does not affect wait-times for elective cancer surgeries: an institutional experience73 Use of human collagen mesh for closure of a large abdominal wall defect, after colon cancer surgery, a case report74 The role of miR-200b in pulmonary hypoplasia associated with congenital diaphragmatic hernia75 Systematic review and meta-analysis of electrocautery versus scalpel for incising epidermis and dermis76 Accuracy of sentinel lymph node biopsy for early breast cancer in the community setting in St. John’s, New-foundland: results of a retrospective review77 Acute surgical outcomes in the 80 plus population78 The liberal use of platelets transfusions in the acute phase of trauma resuscitation: a systematic review79 Implementation of an acute care surgical on call program in a Canadian community hospital80 Short-term outcomes following paraesophageal hernia repair in the elderly patient81 First experience with single incision surgery: feasibility in the pediatric population and cost evaluation82 The impact of the establishment of an acute care surgery unit on the outcomes of appendectomies and cholecystectomies83 Description and preliminary evaluation of a low-cost simulator for training and evaluation of flexible endoscopic skills84 Tumour lysis syndrome in metastatic colon cancer: a case report85 Acute care surgery service model implementation study at a single institution86 Colonic disasters approached by emergent subtotal and total colectomy: lessons learned from 120 consecutive cases87 Acellular collagen matrix stent to protect bowel anastomoses88 Lessons we learned from preoperative MRI-guided wire localization of breast lesions: the University Health Network (UHN) experience89 Interim cost comparison for the use of platinum micro-coils in the operative localization of small peripheral lung nodules90 Routine barium esophagram has minimal impact on the postoperative management of patients undergoing esophagectomy for esophageal cancer91 Iron deficiency anemia is a common presenting issue with giant paraesophageal hernia and resolves following repair92 A randomized comparison of different ventilation strategies during thoracotomy and lung resection93 The Canadian Lung Volume Reduction Surgery study: an 8-year follow-up94 A comparison of minimally invasive versus open Ivor-Lewis esophagectomy95 A new paradigm in the follow-up after curative resection for lung cancer: minimal-dose CT scan allows for early detection of asymptomatic cancer activity96 Predictors of lymph node metastasis in early esophageal adenocarcinoma: Is endoscopic resection worth the risk?97 How well can thoracic surgery residents operate? Comparing resident and program director opinions98 The impact of extremes of age on short- and long-term outcomes following surgical resection of esophageal malignancy99 Epidermal growth factor receptor targeted gold nanoparticles for the enhanced radiation treatment of non–small cell lung cancer100 Laparoscopic Heller myotomy results in excellent outcomes in all subtypes of achalasia as defined by the Chicago classification101 Neoadjuvant chemoradiation versus surgery in managing esophageal cancer102 Quality of life postesophagectomy for cancer!103 The implementation, evolution and translocation of standardized clinical pathways can improve perioperative outcomes following surgical treatment of esophageal cancer104 A tissue-mimicking phantom for applications in thoracic surgical simulation105 Sublobar resection compared with lobectomy for early stage non–small cell lung cancer: a single institution study106 Not all reviews are equal: the quality of systematic reviews and meta-analyses in thoracic surgery107 Do postoperative complications affect health-related quality of life after video-assisted thoracoscopic lobectomy for patients with lung cancer? A cohort study108 Thoracoscopic plication for palliation of dyspnea secondary to unilateral diaphragmatic paralysis: A worthwhile venture?109 Thoracic surgery experience in Canadian general surgery residency programs110 Perioperative morbidity and pathologic response rates following neoadjuvant chemotherapy and chemoradiation for locally advanced esophageal carcinoma111 An enhanced recovery pathway reduces length of stay after esophagectomy112 Predictors of dysplastic and neoplastic progression of Barrett’s esophagus113 Recurrent esophageal cancer complicated by tracheoesophageal fistula: management by means of palliative airway stenting114 Pancreaticopleural fistula-induced empyema thoracis: principles and results of surgical management115 Prognostic factors of early postoperative mortality following right extended hepatectomy116 Optimizing steatotic livers for transplantation using a cell-penetrating peptide CPP-fused heme oxygenase117 Video outlining the technical steps for a robot-assisted laparoscopic pancreaticoduodenectomy118 Establishment of a collaborative group to conduct innovative clinical trials in Canada119 Hepatic resection for metastatic malignant melanoma: a systematic review and meta-analysis120 Acellular normothermic ex vivo liver perfusion for donor liver preservation121 Pancreatic cancer and predictors of survival: comparing the CA 19–9/bilirubin ratio with the McGill Brisbane Scoring System122 Staged liver resections for bilobar hepatic colorectal metastases: a single centre experience123 Economic model of observation versus immediate resection of hepatic adenomas124 Resection of colorectal liver metastasis in the elderly125 Acceptable long-term survival in patients undergoing liver resection for metastases from noncolorectal, non-neuroendocrine, nonsarcoma malignancies126 Patient and clinicopathological features and prognosis of CK19+ hepatocellular carcinomas: a case–control study127 The management of blunt hepatic trauma in the age of angioembolization: a single centre experience128 Liver resections for noncolorectal and non-neuroendocrine metastases: an evaluation of oncologic outcomes129 Developing an evidence-based clinical pathway for patients undergoing pancreaticoduodenectomy130 Hepatitis C infection and hepatocellular carcinoma in liver transplant: a 20 year experience131 The effect of medication on the risk of post-ERCP pancreatitis132 Temporal trends in the use of diagnostic imaging for patients with hepato-pancreato-biliary (HPB) conditions: How much ionizing radiation are we really using?196 A phase II study of aggressive metastasectomy for intra-and extrahepatic metastases from colorectal cancer133 Why do women choose mastectomy for breast cancer treatment? A conceptual framework for understanding surgical decision-making in early-stage breast cancer134 Synoptic operative reporting: documentation of quality of care data for rectal cancer surgery135 Learning curve analysis for cytoreductive surgery: a useful application of the cumulative sum (CUSUM) method136 Pancreatic cancer is strongly associated with a unique urinary metabolomic signature137 Concurrent neoadjuvant chemo/radiation in locally advanced breast cancer138 Impact of positron emission tomography on clinical staging of newly diagnosed rectal cancer: a specialized single centre retrospective study139 An evaluation of intraoperative Faxitron microradiography versus conventional specimen radiography for the excision of nonpalpable breast lesions140 Comparison of breast cancer treatment wait-times in the Southern Interior of British Columbia in 2006 and 2010141 Factors affecting lymph nodes harvest in colorectal carcinoma142 Laparoscopic adrenalectomy for metastases143 You have a message! Social networking as a motivator for fundamentals of laparoscopic surgery (FLS) training144 The evaluation and validation of a rapid diagnostic and support clinic for women assessment for breast cancer145 Oncoplastic breast surgery: oncologic benefits and limitations146 A qualitative study on rectal cancer patients’ preferences for location of surgical care147 The effect of surgery on local recurrence in young women with breast cancer148 Elevated IL-6 and IL-8 levels in tumour microenvironment is not associated with increased serum levels in humans with Pseudomyxoma peritonei and peritoneal mesothelioma149 Conversion from laparoscopic to open approach during gastrectomy: a population-based analysis150 A scoping review of surgical process improvement tools (SPITs) in cancer surgery151 Splenectomy during gastric cancer surgery: a population-based study152 Defining the polo-like kinase 4 (Plk4) interactome in cancer cell protrusions153 Neoadjuvant imatinib mesylate for locally advanced gastrointestinal stromal tumours154 Implementing results from ACOSOG Z0011: Practice-changing or practice-affirming?155 Should lymph node retrieval be a surgical quality indicator in colon cancer?156 Long-term outcomes following resection of retroperitoneal recurrence of colorectal cancer157 Clinical research in surgical oncology: an analysis of clinicaltrials.gov158 Radiation therapy after breast conserving surgery: When are we missing the mark?159 The accuracy of endorectal ultrasound in staging rectal lesions in patients undergoing transanal endoscopic microsurgery160 Quality improvement in gastrointestinal cancer surgery: expert panel recommendations for priority research areas161 Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study162 Papillary thyroid microcarcinoma: Does size matter?163 Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials164 Adherence to antiestrogen therapy in seniors with breast cancer: How well are we doing?165 Parathyroid carcinoma: Challenging the surgical dogma?166 A qualitative assessment of the journey to delayed breast reconstruction195 The role of yoga therapy in breast cancer patients167 Outcomes reported in comparative studies of surgical interventions168 Enhanced recovery pathways decrease length of stay following colorectal surgery, but how quickly do patients actually recover?169 The impact of complications on bed utilization after elective colorectal resection170 Impact of trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study171 Complex fistula-in-ano: Should the plug be abandoned in favour of the LIFT or BioLIFT?172 Prognostic utility of cyclooxygenase-2 expression by colon and rectal cancer173 Laparoscopic right hemicolectomy with complete mesocolic excision provides acceptable perioperative outcomes but is complex and time-consuming: analysis of learning curves for a novice minimally invasive surgeon174 Intraoperative quality assessment following double stapled circular colorectal anastomosis175 Improving patient outcomes through quality assessment of rectal cancer care176 Are physicians willing to accept a decrease in treatment effectiveness for improved functional outcomes for low rectal cancer?177 Turnbull-Cutait delayed coloanal anastomosis for the treatment of distal rectal cancer: a prospective cohort study178 Preoperative high-dose rate brachytherapy in preparation for sphincter preservation surgery for patients with advanced cancer of the lower rectum179 Impact of an enhanced recovery program on short-term outcomes after scheduled laparoscopic colon resection180 The clinical results of the Turnbull-Cutait delayed coloanal anastomosis: a systematic review181 Is a vertical rectus abdominus flap (VRAM) necessary? An analysis of perineal wound complications182 Fistula plug versus endorectal anal advancement flap for the treatment of high transsphincteric cryptoglandular anal fistulas: a systematic review and meta-analysis183 Maternal and neonatal outcomes following colorectal cancer surgery184 Transanal drainage to treat anastomotic leaks after low anterior resection for rectal cancer: a valuable option185 Trends in colon cancer in Ontario: 2002–2009186 Validation of electronically derived short-term outcomes in colorectal surgery187 A population-based assessment of transanal and endoscopic resection for adenocarcinoma of the rectum188 Laparoscopic colorectal surgery in the emergency setting: trends in the province of Ontario from 2002 to 2009189 Prevention of perineal hernia after laparoscopic and robotic abdominoperineal resection: review with case series of internal hernia through pelvic mesh which was placed in attempt to prevent perineal hernia190 Effect of rectal cancer treatments on quality of life191 The use of antibacterial sutures as an adjunctive preventative strategy for surgical site infection in Canada: an economic analysis192 Impact of socioeconomic status on colorectal cancer screening and stage at presentation: preliminary results of a population-based study from an urban Canadian centre193 Initial perioperative results of the first transanal endoscopic microsurgery (TEM) program in the province of Quebec194 Use of negative pressure wound therapy decreases perineal wound infections following abdominal perineal resection. Can J Surg 2012; 55:S63-S135. [DOI: 10.1503/cjs.016712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
47
|
Glew MD, Veith PD, Peng B, Chen YY, Gorasia DG, Yang Q, Slakeski N, Chen D, Moore C, Crawford S, Reynolds EC. PG0026 is the C-terminal signal peptidase of a novel secretion system of Porphyromonas gingivalis. J Biol Chem 2012; 287:24605-17. [PMID: 22593568 DOI: 10.1074/jbc.m112.369223] [Citation(s) in RCA: 111] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Protein substrates of a novel secretion system of Porphyromonas gingivalis contain a conserved C-terminal domain (CTD) of ∼70-80 amino acid residues that is essential for their secretion and attachment to the cell surface. The CTD itself has not been detected in mature substrates, suggesting that it may be removed by a novel signal peptidase. More than 10 proteins have been shown to be essential for the proper functioning of the secretion system, and one of these, PG0026, is a predicted cysteine proteinase that also contains a CTD, suggesting that it may be a secreted component of the secretion system and a candidate for being the CTD signal peptidase. A PG0026 deletion mutant was constructed along with a PG0026C690A targeted mutant encoding an altered catalytic Cys residue. Analysis of clarified culture fluid fractions by SDS-PAGE and mass spectrometry revealed that the CTD was released intact into the surrounding medium in the wild type strain, but not in the PG0026 mutant strains. Western blot experiments revealed that the maturation of a model substrate was stalled at the CTD-removal step specifically in the PG0026 mutants, and whole cell ELISA experiments demonstrated partial secretion of substrates to the cell surface. The CTD was also shown to be accessible at the cell surface in the PG0026 mutants, suggesting that the CTD was secreted but could not be cleaved. The data indicate that PG0026 is responsible for the cleavage of the CTD signal after substrates are secreted across the OM.
Collapse
Affiliation(s)
- Michelle D Glew
- Oral Health Cooperative Research Centre, Melbourne Dental School, and Bio21 Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
|
49
|
Lin W, Beattie M, Crawford S, Gold E, Chen LM, Rosen M. Impact of smoking on the age at natural menopause in BRCA1/2 mutation carriers in northern california. Fertil Steril 2011. [DOI: 10.1016/j.fertnstert.2011.07.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
50
|
Chiu JC, Shi X, Karmali S, Birch DW, Apriasz I, Alkhamesi NA, Lal A, Schlachta CM, Christou NV, Elkassem S, Lindsay D, Smith L, Sullivan P, Sockalingam S, Hawa R, Wnuk S, Jackson T, Okrainec A, Fayez R, Christou NV, Court O, Mueller C, Okrainec A, Sockalingham S, Jackson T, Mueller C, Swanson T, Daigle C, Okrainec A, Pitzul K, Penner T, Urbach DR, Jackson T, Sandhu L, Maciver A, McCall M, Edgar R, Thiesen A, Bigam D, Churchill T, Shapiro AMJ, Luu S, Regehr G, Murnaghan ML, Gallinger S, Moulton CA, Palter V, Grantcharov T, Dath D, Hoogenes J, Matsumoto E, Szalay D, Fox A, Pitzul K, Bhojani F, Kaplan M, Wei A, McGilvray I, Cleary SP, Okrainec A, Alqahtani A, Parsyan A, Payne R, Tabah R, Anantha R, Vogt K, Crawford S, Parry N, Leslie K, Ochs A, Matthew K, Khadaroo R, Churchill T, Lavoie JM, Zalai C, Vasilevsky CA, Booy J, Takata J, Tomlinson G, Urbach DR, Lim D, Tomlinson C, LaBossiere J, Rommens K, Birch DW, Brenneman F, MacLellan S, Simpson J, Asai K, Elgadi K, Ali S, Sawyer J, Helewa R, Turner D, Wirtzfeld D, Park J, Czaykowski P, Mak G, Hochman D, McKay A, Gill R, Al-Adra D, Shi X, Sample C, Armstrong J, Lester L, Vogt K, Brackstone M, Lee L, Kaneva P, Liberman S, Charlebois P, Stein B, Fried G, Feldman L, Kanji A, Sharon E, Asai K, Jacks L, McCready D, Ghazarian D, Leong WL, Wu R, Okrainec A, Penner T, Ball C, Kirkpatrick A, Vasquez A, Balakrishnan L, Miller G, Awan S, Azadeh NR, Hoogenes J, Dath D, Jain V, Busato GM, Cristea O, Landau J, Moreland R, Johnson M, Ramage D, Browning D, Ullah S, Cristea O, Bodrogi A, Johnson M, McAlister V, Palisoc J, Anderson J, Kiladze R, Ciar J, Bancel I, Pitzul K, Leake PA, Okrainec A, Dalvi A, McLean R, Stephen W, Loeb M, Smith R, Christoffersen E, Forbes S, Kidane B, Vogt K, Vinden C, Ahmadi N, Dubois L, McKenzie M, Baxter N, Brown C, Chaudhury P, Dixon E, Fitzgerald W, Henteleff H, Kirkpatrick A, Latosinsky S, MacLean A, McLeod R, Pearsall E, Aarts MA, Meghji Z, McLeod R, Okrainec A, Tran T, Kaneva P, Fried G, Mayo N, Feldman L, Newman D, Bergman S, Cummings BA, Delisle M, Whitehead V, Chertkow H, Chan T, Cicero M, Perampaladas K, Bandukwala T, Struble J, Moser M, Young P, Groeneveld A, Chan P, Smith S, Khadaroo R, Buczkowski A, Hameed M, Tan-Tam C, Meneghetti A, Simons R, Panton N, Elnahas A, Ghaderi I, Madani A, de Gara C, Schlachta CM, Kalechstein S, Pitzul K, Henao O, Okrainec A, Paskar D, Croome K, Hernandez R, Knapp G, Howatt N, Foster S, Cameron B, Austin J, Mack L, Temple W, Puloski S, Schachar N, Gill T, Doris P, Tecson A, Kolozsvari N, Andalib A, Kaneva P, Cao J, Vassiliou M, Fried G, Feldman L, Kolozsvari N, Kaneva P, Vassiliou M, Fried G, Feldman L, Kolozsvari N, Kaneva P, Brace C, Chartrand G, Vaillancourt M, Cao J, Banaszek D, Vassiliou M, Fried G, Feldman L, Fraser S, Bergman S, Deobald R, Chad J, Di Gregorio C, Johnstone J, Kenyon C, Lees M, Auger-Dufour E, Fried G, Feldman L, Ferri L, Vassiliou M, Alqahtani A, Perlman R, Holcroft C, Gordon PH, Szilagyi A, Iradukunda D, Moser MAJ, Rodych N, Shaw JM, Ahmed N, Chiu M, Kurabi B, Qureshi A, Nathens A, Conn LG, Pandya A, Kitto S, Ma G, Pooni A, Forbes S, Eskicioglu C, Pearsall E, Brenneman F, McLeod R, Rockx MA, McAlister V, Roberts D, Ouellet J, Kirkpatrick A, Lall R, Sutherland F, Ball C, Chackungal S, Knowlton LM, Dahn B, McQueen K, Morrison JA, Lent B, Brown J, Fluit M, Herbert C, Deen S, Deutschmann M, McFadden S, Gelfand G, Bosch D, Grimmer L, Milman S, Ng T, Gill R, Perry T, Abele J, Bedard E, Schiller D, Coughlin S, Stewart TC, Parry N, Gray D, Williamson J, Malthaner R, Bottoni D, Perri M, Trejos AL, Naish M, Patel R, Malthaner R, Ashrafi A, Bond J, Ong S, Yamashita M, Ahmadi S, Abdulmosen M, Miller J, Finley C, Ostrander K, Shargall Y, Lee L, Hanley S, Robineau C, Sirois C, Mulder D, Ferri L, Humphrey R, Inculet R, Fortin D, Arab A, Malthaner R, Ashrafi A, Bond J, Ong S, Yamashita M, Ahmadi S, McGuire A, Reid K, Petsikas D, Hopman W, Basi A, Basi S, Irshad K, Hanna W, Croome KP, Marotta P, McAlister V, Quan D, Wall W, Hernandez-Alejandro R, de Mestral C, Zagorski B, Rotstein O, Gomez D, Haas B, Laupacis A, Sharma S, Bridge J, Nathens A, Bhojani F, Fox A, Pitzul K, Moulton CA, Wei A, Okrainec A, Cleary S, Bertens K, Croome KP, Mujoomdar A, Peck D, Rankin R, Quan D, Kakani N, Hernandez-Alejandro R, Suri R, Marcaccio M, Ruo L, Jamal M, Khalil JA, Simoneau-Beaudry E, Dumitra S, Edwards M, Yousef Y, Jiffry MA, Metrakos P, Tchervenkov J, Doi S, Barkun J, Obayan A, Meiers S, Keith R, Elkassem S, Church N, Mitchell P, Turbide C, Dixon E, Debru E, Shum J, Wall WJ, Maniar R, Hochman D, Wirtzfeld D, Yaffe C, Yip B, McKay A, Silverman R, Park J, Francescutti V, Rivera L, Kane JM, Skitzki JJ, Lovrics P, Hodgson N, O'Brien MA, Thabane L, Cornacchi S, Heller B, Reid S, Sanders K, Kittmer T, Simunovic M, Duhaime S, Fong B, Deria M, Acton C, El-Maadawy M, Lad S, Arnaout A, Omole M, Pemberton J, Lovrics P, Bischof D, Stotland P, Hagen J, Swallow C, Klein L, Van Koughnett JA, Ahmad T, Ainsworth P, Brackstone M, Kanagaratnam S, Groot G, VanderBeek L, Francescutti V, Farrokhyar F, Strang B, Kahnamoui K, MacLellan S, MacKay H, Ringash J, Jacks L, Kassam Z, Khalili I, Conrad T, Okrainec A, Chagpar R, Xing Y, You N, Yi-Ju C, Feig B, Chang G, Cormie J, Gervais MK, Sideris L, Drolet P, Mitchell A, Leblanc G, Dubé P, Merchant S, Knowling M, Cheifetz R, Raval M, Heidary B, Kalikias S, Raval D, Phang T, Brown C, Scheer A, O'Connor A, Chan B, Moloo H, Poulin E, Mamazza J, Auer R, Boushey R, Hardy K, Vergis A, Sullivan P, Musselman R, Gomes T, Chan B, Auer R, Moloo H, Poulin E, Mamazza J, Al-Khayal K, Al-Omran M, Mamdani M, AlObeed O, Boushey R, Martel G, Crawford A, Barkun J, Ramsay C, Fergusson D, Boushey R, Williams L, Crawford A, McLaughlin K, Mackey M, Moloo H, Mamazza J, Poulin E, Friedlich M, Boushey R, Auer R, Bellolio F, Cohen Z, MacRae H, O'Connor B, Huang H, Victor JC, McLeod R, Hardy K, Pitzul K, Kwong J, Vergis A, Urbach D, Okrainec A, Vogt K, Dubois L, Vinden C, Chan B, Scheer A, Menezes A, Moloo H, Poulin E, Boushey R, Mamazza J, Bellolio F, MacRae H, Cohen Z, O'Connor B, Huang H, McLeod R, Godbout-Simard C, Azar J, Psaradellis F, Sampalis J, Morin N, Brown C, Kalikias S, Heidary B, Raval D, Phang PT, Raval M, Archibald A, Hurlbut D, Vanner S, Zalai C, Vasilevsky CA, Simunovic M, Cadeddu M, Forbes S, Kelly S, Stephen W, Grubac V, Marcinow M, Coates A, Aslani N, Phang PT, Raval M, Brown C, Scheer A, Carrier M, Boushey R, Asmis T, Wells P, Jonker D, Auer R, Azer N, Gill R, de Gara C, Birch DW, Karmali S, Roxin G, Drolet S, MacLean A, Buie WD, Heine J, Agzarian J, Forbes S, Stephen W, Kelly S, Churchill P, Corner T, Kelly S, Forbes S, Lindsay L, Stephen W, Scheer A, O'Connor A, Chan B, Moloo H, Poulin E, Mamazza J, Auer R, Boushey R, Denis J, Hochman D, Recsky M, Phang PT, Raval M, Cheung W, Brown C, Alkhamesi N, Schlachta CM, Tiwari T, Brown C, Raval MJ, Phang PT. Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011. Can J Surg 2011; 54:S57-S104. [PMID: 35488394 PMCID: PMC3191910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023] Open
Affiliation(s)
- J C Chiu
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - X Shi
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - S Karmali
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - D W Birch
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - I Apriasz
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | - N A Alkhamesi
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | - A Lal
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | - C M Schlachta
- From the Schulich School of Medicine and Dentistry and the London Health Sciences Centre, London, Ont
| | | | - S Elkassem
- From the University of Toronto, Toronto, Ont
| | - D Lindsay
- From the University of Toronto, Toronto, Ont
| | - L Smith
- From the University of Toronto, Toronto, Ont
| | - P Sullivan
- From the University of Toronto, Toronto, Ont
| | - S Sockalingam
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - R Hawa
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - S Wnuk
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - T Jackson
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Ont
| | - R Fayez
- From the McGill University Health Centre, Montréal, Que
| | - N V Christou
- From the McGill University Health Centre, Montréal, Que
| | - O Court
- From the McGill University Health Centre, Montréal, Que
| | - C Mueller
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - S Sockalingham
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Jackson
- From the Division of General Surgery and Division of Psychiatry, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - C Mueller
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Swanson
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - C Daigle
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - K Pitzul
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Penner
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - D R Urbach
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - T Jackson
- From the Division of General Surgery, University Health Network, Department of Surgery, University of Toronto, Toronto, Ont
| | - L Sandhu
- From the University of Toronto, Toronto, Ont
| | - A Maciver
- From the University of Alberta, Edmonton, Alta
| | - M McCall
- From the University of Alberta, Edmonton, Alta
| | - R Edgar
- From the University of Alberta, Edmonton, Alta
| | - A Thiesen
- From the University of Alberta, Edmonton, Alta
| | - D Bigam
- From the University of Alberta, Edmonton, Alta
| | - T Churchill
- From the University of Alberta, Edmonton, Alta
| | | | - S Luu
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - G Regehr
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - M L Murnaghan
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - S Gallinger
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - C-A Moulton
- From the Wilson Centre, University Health Network, Department of Surgery, University of Toronto, Hospital for Sick Children, Toronto, Ont., and the Centre for Health Education Scholarship, University of British Columbia, Vancouver, BC
| | - V Palter
- From St. Michael's Hospital, University of Toronto, Toronto, Ont
| | - T Grantcharov
- From St. Michael's Hospital, University of Toronto, Toronto, Ont
| | - D Dath
- From McMaster University, Hamilton, Ont
| | | | | | - D Szalay
- From McMaster University, Hamilton, Ont
| | - A Fox
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - K Pitzul
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - F Bhojani
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - M Kaplan
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - A Wei
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - I McGilvray
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - S P Cleary
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | - A Okrainec
- From University of Toronto, Toronto Western Hospital, Toronto, Ont
| | | | - A Parsyan
- From McGill University, Montréal, Que
| | - R Payne
- From McGill University, Montréal, Que
| | - R Tabah
- From McGill University, Montréal, Que
| | - R Anantha
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - K Vogt
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - S Crawford
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - N Parry
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - K Leslie
- From the Division of General Surgery, Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London, Ont
| | - A Ochs
- From the University of Alberta, Edmonton, Alta
| | - K Matthew
- From the University of Alberta, Edmonton, Alta
| | - R Khadaroo
- From the University of Alberta, Edmonton, Alta
| | - T Churchill
- From the University of Alberta, Edmonton, Alta
| | | | - C Zalai
- From McGill University, Montréal, Que
| | | | - J Booy
- From the University Health Network, Toronto, Ont
| | - J Takata
- From the University Health Network, Toronto, Ont
| | - G Tomlinson
- From the University Health Network, Toronto, Ont
| | - D R Urbach
- From the University Health Network, Toronto, Ont
| | - D Lim
- From the University of Alberta, Edmonton, Alta
| | - C Tomlinson
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - J LaBossiere
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - K Rommens
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - D W Birch
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - F Brenneman
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - S MacLellan
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - J Simpson
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - K Asai
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - K Elgadi
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - S Ali
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - J Sawyer
- From Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont
| | - R Helewa
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - D Turner
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - D Wirtzfeld
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - J Park
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - P Czaykowski
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - G Mak
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - D Hochman
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - A McKay
- From the University of Manitoba, CancerCare Manitoba, Winnipeg, Man
| | - R Gill
- From the University of Alberta, Edmonton, Alta
| | - D Al-Adra
- From the University of Alberta, Edmonton, Alta
| | - X Shi
- From the University of Alberta, Edmonton, Alta
| | - C Sample
- From the University of Alberta, Edmonton, Alta
| | - J Armstrong
- From the University of Western Ontario, London, Ont
| | - L Lester
- From the University of Western Ontario, London, Ont
| | - K Vogt
- From the University of Western Ontario, London, Ont
| | - M Brackstone
- From the University of Western Ontario, London, Ont
| | - L Lee
- From the McGill University Health Centre, Montréal, Que
| | - P Kaneva
- From the McGill University Health Centre, Montréal, Que
| | - S Liberman
- From the McGill University Health Centre, Montréal, Que
| | - P Charlebois
- From the McGill University Health Centre, Montréal, Que
| | - B Stein
- From the McGill University Health Centre, Montréal, Que
| | - G Fried
- From the McGill University Health Centre, Montréal, Que
| | - L Feldman
- From the McGill University Health Centre, Montréal, Que
| | - A Kanji
- From the University of Toronto, University Health Network, Toronto, Ont
| | - E Sharon
- From the University of Toronto, University Health Network, Toronto, Ont
| | - K Asai
- From the University of Toronto, University Health Network, Toronto, Ont
| | - L Jacks
- From the University of Toronto, University Health Network, Toronto, Ont
| | - D McCready
- From the University of Toronto, University Health Network, Toronto, Ont
| | - D Ghazarian
- From the University of Toronto, University Health Network, Toronto, Ont
| | - W-L Leong
- From the University of Toronto, University Health Network, Toronto, Ont
| | - R Wu
- From The Ottawa Hospital, Ottawa and Toronto Western Hospital, Toronto, Ont
| | - A Okrainec
- From The Ottawa Hospital, Ottawa and Toronto Western Hospital, Toronto, Ont
| | - T Penner
- From The Ottawa Hospital, Ottawa and Toronto Western Hospital, Toronto, Ont
| | - C Ball
- From the University of Calgary, Calgary, Alta
| | | | - A Vasquez
- From the University of Saskatchewan, Saskatoon, Sask
| | | | - G Miller
- From the University of Saskatchewan, Saskatoon, Sask
| | - S Awan
- From the University of Saskatchewan, Saskatoon, Sask
| | | | | | - D Dath
- From McMaster University, Hamilton, Ont
| | - V Jain
- From the University of Western Ontario, London, Ont
| | - G-M Busato
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - O Cristea
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - J Landau
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - R Moreland
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - M Johnson
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - D Ramage
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - D Browning
- From the Schulich School of Medicine and Dentistry, and Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - S Ullah
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - O Cristea
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - A Bodrogi
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - M Johnson
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - V McAlister
- From the Canadian Forces Medical Service and University of Western Ontario, London, Ont
| | - J Palisoc
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - J Anderson
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - R Kiladze
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - J Ciar
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - I Bancel
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - K Pitzul
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - P-A Leake
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - A Okrainec
- From the Division of General Surgery, University Health Network, University of Toronto, Toronto, Ont
| | - A Dalvi
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - R McLean
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - W Stephen
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - M Loeb
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - R Smith
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - E Christoffersen
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - S Forbes
- From the Department of Surgery, Department of Pathology and Molecular Medicine, McMaster University and Hamilton Health Sciences Hamilton, Ont
| | - B Kidane
- From the University of Western Ontario, London, Ont
| | - K Vogt
- From the University of Western Ontario, London, Ont
| | - C Vinden
- From the University of Western Ontario, London, Ont
| | - N Ahmadi
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - L Dubois
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - M McKenzie
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - N Baxter
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - C Brown
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - P Chaudhury
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - E Dixon
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - W Fitzgerald
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - H Henteleff
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - A Kirkpatrick
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - S Latosinsky
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - A MacLean
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - R McLeod
- From the University of Toronto, Toronto, the University of Western Ontario, London, Ont., the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC, McGill University, Montréal, Que., the University of Calgary, Calgary, Alta., Charles S. Curtis Memorial Hospital, St. Anthony, NL, and Dalhousie University, Halifax, NS
| | - E Pearsall
- From the University of Toronto, Toronto, Ont
| | - M-A Aarts
- From the University of Toronto, Toronto, Ont
| | - Z Meghji
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - A Okrainec
- From the University of Toronto, Toronto, Ont
| | - T Tran
- From McGill University, Montréal, Que
| | - P Kaneva
- From McGill University, Montréal, Que
| | - G Fried
- From McGill University, Montréal, Que
| | - N Mayo
- From McGill University, Montréal, Que
| | - L Feldman
- From McGill University, Montréal, Que
| | - D Newman
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - S Bergman
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - B-A Cummings
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - M Delisle
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - V Whitehead
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - H Chertkow
- From McGill University and the Jewish General Hospital, Montréal, Que
| | - T Chan
- From McMaster University, Hamilton, Ont
| | - M Cicero
- From McMaster University, Hamilton, Ont
| | | | | | - J Struble
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask
| | - M Moser
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask
| | - P Young
- From the University of Alberta, Edmonton, Alta
| | | | - P Chan
- From the University of Alberta, Edmonton, Alta
| | - S Smith
- From the University of Alberta, Edmonton, Alta
| | - R Khadaroo
- From the University of Alberta, Edmonton, Alta
| | - A Buczkowski
- From the University of British Columbia, Vancouver, BC
| | - M Hameed
- From the University of British Columbia, Vancouver, BC
| | - C Tan-Tam
- From the University of British Columbia, Vancouver, BC
| | - A Meneghetti
- From the University of British Columbia, Vancouver, BC
| | - R Simons
- From the University of British Columbia, Vancouver, BC
| | - N Panton
- From the University of British Columbia, Vancouver, BC
| | - A Elnahas
- From McMaster University, Hamilton, Ont
| | - I Ghaderi
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - A Madani
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - C de Gara
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - C M Schlachta
- From the University of Western Ontario, London, Ont., and the University of Alberta, Edmonton, Alta
| | - S Kalechstein
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - K Pitzul
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - O Henao
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - A Okrainec
- From McMaster University, Hamilton University Health Network, Hamilton, University of Toronto, Toronto, Ont., and the Hospital Universitario San Vicente Fundacion, Medellin, Colombia
| | - D Paskar
- From the Department of General Surgery, University of Western Ontario, London, Ont
| | - K Croome
- From the Department of General Surgery, University of Western Ontario, London, Ont
| | - R Hernandez
- From the Department of General Surgery, University of Western Ontario, London, Ont
| | - G Knapp
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - N Howatt
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - S Foster
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - B Cameron
- From McMaster University, Hamilton, Ont., and Centro Evangelico de Medicina (CEML) Hospital, Lubango, Angola
| | - J Austin
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - L Mack
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - W Temple
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - S Puloski
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - N Schachar
- From the Foothills Medical Centre and Tom Baker Cancer Centre, Calgary, Alta
| | - T Gill
- From the Surrey Memorial Hospital, New Westminster and Surrey, BC
| | - P Doris
- From the Surrey Memorial Hospital, New Westminster and Surrey, BC
| | - A Tecson
- From the Surrey Memorial Hospital, New Westminster and Surrey, BC
| | - N Kolozsvari
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - A Andalib
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - P Kaneva
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - J Cao
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - M Vassiliou
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - G Fried
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - L Feldman
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - N Kolozsvari
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - P Kaneva
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - M Vassiliou
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - G Fried
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - L Feldman
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que
| | - N Kolozsvari
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - P Kaneva
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - C Brace
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - G Chartrand
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - M Vaillancourt
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - J Cao
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - D Banaszek
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - M Vassiliou
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - G Fried
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - L Feldman
- From the Steinberg-Bernstein Centre for Minimally Invasive Surgery and Innovation, McGill University, Montréal, Que., and Simon Fraser University, Burnaby, BC
| | - S Fraser
- From the Jewish General Hospital, Montréal, Que
| | - S Bergman
- From the Jewish General Hospital, Montréal, Que
| | - R Deobald
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - J Chad
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - C Di Gregorio
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - J Johnstone
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - C Kenyon
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - M Lees
- From the Department of General Surgery and West Winds Primary Health Centre, University of Saskatchewan, Saskatoon, Sask
| | - E Auger-Dufour
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - G Fried
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - L Feldman
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - L Ferri
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - M Vassiliou
- From the McGill University Health Centre, McGill University, Montréal, Que
| | - A Alqahtani
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - R Perlman
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - C Holcroft
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - P H Gordon
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - A Szilagyi
- From the Division of Colorectal Surgery, Department of Epidemiology, Division of Gastroenterology of the Jewish General Hospital, McGill University School of Medicine, Montréal, Que
| | - D Iradukunda
- From the University of Saskatchewan, Saskatoon, Sask
| | - M A J Moser
- From the University of Saskatchewan, Saskatoon, Sask
| | - N Rodych
- From the University of Saskatchewan, Saskatoon, Sask
| | - J M Shaw
- From the University of Saskatchewan, Saskatoon, Sask
| | - N Ahmed
- From the University of Toronto, Toronto, Ont
| | - M Chiu
- From the University of Toronto, Toronto, Ont
| | - B Kurabi
- From the University of Toronto, Toronto, Ont
| | - A Qureshi
- From the University of Toronto, Toronto, Ont
| | - A Nathens
- From the University of Toronto, Toronto, Ont
| | | | - A Pandya
- From the University of Toronto, Toronto, Ont
| | - S Kitto
- From the University of Toronto, Toronto, Ont
| | - G Ma
- From the University of Toronto, Toronto, Ont
| | - A Pooni
- From the University of Toronto, Toronto, Ont
| | - S Forbes
- From the University of Toronto, Toronto, Ont
| | | | - E Pearsall
- From the University of Toronto, Toronto, Ont
| | - F Brenneman
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - M A Rockx
- From the Alberta Medical Association Locum Services and the University of Western Ontario, London, Ont
| | - V McAlister
- From the Alberta Medical Association Locum Services and the University of Western Ontario, London, Ont
| | - D Roberts
- From the University of Calgary, Calgary, Alta
| | - J Ouellet
- From the University of Calgary, Calgary, Alta
| | | | - R Lall
- From the University of Calgary, Calgary, Alta
| | | | - C Ball
- From the University of Calgary, Calgary, Alta
| | - S Chackungal
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - L M Knowlton
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - B Dahn
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - K McQueen
- From the University of Western Ontario, London, Ont., the University of British Columbia, Vancouver, BC, the Ministry of Health Liberia, Monrovia, Liberia, and Harvard Humanitarian Initiative, Cambridge, Mass
| | - J A Morrison
- From the Chatham Kent Health Alliance, Chatham, Ont
| | - B Lent
- From the University of Western Ontario, London, Ont
| | - J Brown
- From the University of Western Ontario, London, Ont
| | - M Fluit
- From the University of Western Ontario, London, Ont
| | - C Herbert
- From the University of Western Ontario, London, Ont
| | - S Deen
- From the University of Calgary, Calgary, Alta
| | | | - S McFadden
- From the University of Calgary, Calgary, Alta
| | - G Gelfand
- From the University of Calgary, Calgary, Alta
| | - D Bosch
- From the University of Calgary, Calgary, Alta
| | - L Grimmer
- From the Brown University School of Medicine, Providence, RI
| | - S Milman
- From the Brown University School of Medicine, Providence, RI
| | - T Ng
- From the Brown University School of Medicine, Providence, RI
| | - R Gill
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - T Perry
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - J Abele
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - E Bedard
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - D Schiller
- From the University of Alberta, the Cross Cancer Institute, Edmonton, Alta
| | - S Coughlin
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - T Charyk Stewart
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - N Parry
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - D Gray
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - J Williamson
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - R Malthaner
- From the University of Western Ontario, London Health Sciences Centre, London, Ont
| | - D Bottoni
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - M Perri
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - A L Trejos
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - M Naish
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - R Patel
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - R Malthaner
- From the London Health Sciences Centre and CSTAR, London, Ont
| | - A Ashrafi
- From the Surrey Memorial Hospital, Surrey, BC
| | - J Bond
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ong
- From the Surrey Memorial Hospital, Surrey, BC
| | - M Yamashita
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ahmadi
- From the Surrey Memorial Hospital, Surrey, BC
| | | | - J Miller
- From McMaster University, Hamilton, Ont
| | - C Finley
- From McMaster University, Hamilton, Ont
| | | | | | - L Lee
- From the McGill University Health Centre, Montréal, Que
| | - S Hanley
- From the McGill University Health Centre, Montréal, Que
| | - C Robineau
- From the McGill University Health Centre, Montréal, Que
| | - C Sirois
- From the McGill University Health Centre, Montréal, Que
| | - D Mulder
- From the McGill University Health Centre, Montréal, Que
| | - L Ferri
- From the McGill University Health Centre, Montréal, Que
| | - R Humphrey
- From the University of Western Ontario, Woodstock, and London, Ont
| | - R Inculet
- From the University of Western Ontario, Woodstock, and London, Ont
| | - D Fortin
- From the University of Western Ontario, Woodstock, and London, Ont
| | - A Arab
- From the University of Western Ontario, Woodstock, and London, Ont
| | - R Malthaner
- From the University of Western Ontario, Woodstock, and London, Ont
| | - A Ashrafi
- From the Surrey Memorial Hospital, Surrey, BC
| | - J Bond
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ong
- From the Surrey Memorial Hospital, Surrey, BC
| | - M Yamashita
- From the Surrey Memorial Hospital, Surrey, BC
| | - S Ahmadi
- From the Surrey Memorial Hospital, Surrey, BC
| | - A McGuire
- From Queen's University, Ottawa and Kingston, Ont
| | - K Reid
- From Queen's University, Ottawa and Kingston, Ont
| | - D Petsikas
- From Queen's University, Ottawa and Kingston, Ont
| | - W Hopman
- From Queen's University, Ottawa and Kingston, Ont
| | - A Basi
- From the University of Western Ontario, London, and the William Osler Health Centre, Brampton, Ont
| | - S Basi
- From the University of Western Ontario, London, and the William Osler Health Centre, Brampton, Ont
| | - K Irshad
- From the University of Western Ontario, London, and the William Osler Health Centre, Brampton, Ont
| | - W Hanna
- From the Toronto General Hospital, Toronto, Ont
| | - K P Croome
- From the University of Western Ontario, London, Ont
| | - P Marotta
- From the University of Western Ontario, London, Ont
| | - V McAlister
- From the University of Western Ontario, London, Ont
| | - D Quan
- From the University of Western Ontario, London, Ont
| | - W Wall
- From the University of Western Ontario, London, Ont
| | | | - C de Mestral
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - B Zagorski
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - O Rotstein
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - D Gomez
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - B Haas
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - A Laupacis
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - S Sharma
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - J Bridge
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - A Nathens
- From the Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto and Institute for Clinical Evaluative Sciences, Toronto, Ont
| | - F Bhojani
- From the University of Toronto, Toronto, Ont
| | - A Fox
- From the University of Toronto, Toronto, Ont
| | - K Pitzul
- From the University of Toronto, Toronto, Ont
| | - C-A Moulton
- From the University of Toronto, Toronto, Ont
| | - A Wei
- From the University of Toronto, Toronto, Ont
| | - A Okrainec
- From the University of Toronto, Toronto, Ont
| | - S Cleary
- From the University of Toronto, Toronto, Ont
| | - K Bertens
- From the University of Western Ontario, London, Ont
| | - K P Croome
- From the University of Western Ontario, London, Ont
| | - A Mujoomdar
- From the University of Western Ontario, London, Ont
| | - D Peck
- From the University of Western Ontario, London, Ont
| | - R Rankin
- From the University of Western Ontario, London, Ont
| | - D Quan
- From the University of Western Ontario, London, Ont
| | - N Kakani
- From the University of Western Ontario, London, Ont
| | | | - R Suri
- From McMaster University, Hamilton, Ont
| | | | - L Ruo
- From McMaster University, Hamilton, Ont
| | - M Jamal
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - J Abou Khalil
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - E Simoneau-Beaudry
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - S Dumitra
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - M Edwards
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - Y Yousef
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - M Al Jiffry
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - P Metrakos
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - J Tchervenkov
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - S Doi
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - J Barkun
- From McGill University, Montréal, Que., and University of Queensland, School of Public Health, Brisbane, Queensland, Australia
| | - A Obayan
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask., and the Regina General Hospital, Regina, Sask
| | - S Meiers
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask., and the Regina General Hospital, Regina, Sask
| | - R Keith
- From the Department of Surgery, University of Saskatchewan, Saskatoon, Sask., and the Regina General Hospital, Regina, Sask
| | - S Elkassem
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - N Church
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - P Mitchell
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - C Turbide
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - E Dixon
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - E Debru
- From the University of Toronto, Toronto, Ont., and the University of Calgary, Calgary, Alta
| | - J Shum
- From the University of Western Ontario, London, Ont
| | - W J Wall
- From the University of Western Ontario, London, Ont
| | - R Maniar
- From the University of Manitoba, Winnipeg, Man
| | - D Hochman
- From the University of Manitoba, Winnipeg, Man
| | - D Wirtzfeld
- From the University of Manitoba, Winnipeg, Man
| | - C Yaffe
- From the University of Manitoba, Winnipeg, Man
| | - B Yip
- From the University of Manitoba, Winnipeg, Man
| | - A McKay
- From the University of Manitoba, Winnipeg, Man
| | - R Silverman
- From the University of Manitoba, Winnipeg, Man
| | - J Park
- From the University of Manitoba, Winnipeg, Man
| | - V Francescutti
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - L Rivera
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - J M Kane
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - J J Skitzki
- From the Roswell Park Cancer Institute, Buffalo, New York, NY
| | - P Lovrics
- From McMaster University, Hamilton, Ont
| | - N Hodgson
- From McMaster University, Hamilton, Ont
| | | | - L Thabane
- From McMaster University, Hamilton, Ont
| | | | - B Heller
- From McMaster University, Hamilton, Ont
| | - S Reid
- From McMaster University, Hamilton, Ont
| | - K Sanders
- From McMaster University, Hamilton, Ont
| | - T Kittmer
- From McMaster University, Hamilton, Ont
| | | | - S Duhaime
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - B Fong
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - M Deria
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - C Acton
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - M El-Maadawy
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - S Lad
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - A Arnaout
- From the University of Ottawa, Ottawa, Ont., and The Ottawa Hospital, Ottawa, Ont
| | - M Omole
- From McMaster University, Hamilton, Ont
| | | | - P Lovrics
- From McMaster University, Hamilton, Ont
| | - D Bischof
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - P Stotland
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - J Hagen
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - C Swallow
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - L Klein
- From North York General Hospital, Mount Sinai Hospital, Humber River Regional Hospital and the University of Toronto, Toronto, Ont
| | - J A Van Koughnett
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | - T Ahmad
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | - P Ainsworth
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | - M Brackstone
- From the Division of General Surgery, University of Western Ontario, and the London Regional Cancer Program, London, Ont
| | | | - G Groot
- From the University of Saskatchewan, Saskatoon, Sask
| | | | | | | | - B Strang
- From McMaster University, Hamilton, Ont
| | | | - S MacLellan
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - H MacKay
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - J Ringash
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - L Jacks
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - Z Kassam
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - I Khalili
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - T Conrad
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - A Okrainec
- From the Department of Radiology, Department of Surgery, Princess Margaret Hospital, University Health Network, University of Toronto, Cancer Care Ontario, Toronto, Ont
| | - R Chagpar
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - Y Xing
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - N You
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - C Yi-Ju
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - B Feig
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - G Chang
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - J Cormie
- From the University of Western Ontario, London, Ont., and the MD Anderson Cancer Center, Houston, Tex
| | - M-K Gervais
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - L Sideris
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - P Drolet
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - A Mitchell
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - G Leblanc
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - P Dubé
- From Hôpital Maisonneuve-Rosemont, Montréal, Que
| | - S Merchant
- From the University of British Columbia, General Surgery, and the BC Cancer Agency, Vancouver, BC
| | - M Knowling
- From the University of British Columbia, General Surgery, and the BC Cancer Agency, Vancouver, BC
| | - R Cheifetz
- From the University of British Columbia, General Surgery, and the BC Cancer Agency, Vancouver, BC
| | - M Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - B Heidary
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - S Kalikias
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - D Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - T Phang
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - A Scheer
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - A O'Connor
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - B Chan
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - H Moloo
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - E Poulin
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - J Mamazza
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - R Auer
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - R Boushey
- From The Ottawa Hospital, University of Ottawa, Ottawa, Ont
| | - K Hardy
- From the University of Manitoba, Winnipeg, Man., and the University of Toronto, Toronto, Ont
| | - A Vergis
- From the University of Manitoba, Winnipeg, Man., and the University of Toronto, Toronto, Ont
| | - P Sullivan
- From the University of Manitoba, Winnipeg, Man., and the University of Toronto, Toronto, Ont
| | - R Musselman
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - T Gomes
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - B Chan
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - R Auer
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - H Moloo
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - E Poulin
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - J Mamazza
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - K Al-Khayal
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - M Al-Omran
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - M Mamdani
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - O AlObeed
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - R Boushey
- From The Ottawa Hospital, University of Ottawa, Ottawa, Institute for Clinical Evaluative Sciences, Li Ka Shing Knowledge Institute of St. Michael's, Toronto, Ont., and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
| | - G Martel
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - A Crawford
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - J Barkun
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - C Ramsay
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - D Fergusson
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - R Boushey
- From the University of Ottawa, Ottawa, Ont., McGill University, Montréal, Que., and the University of Aberdeen, Aberdeen, Great Britain
| | - L Williams
- From the University of Ottawa, Ottawa, Ont
| | - A Crawford
- From the University of Ottawa, Ottawa, Ont
| | | | - M Mackey
- From the University of Ottawa, Ottawa, Ont
| | - H Moloo
- From the University of Ottawa, Ottawa, Ont
| | - J Mamazza
- From the University of Ottawa, Ottawa, Ont
| | - E Poulin
- From the University of Ottawa, Ottawa, Ont
| | | | - R Boushey
- From the University of Ottawa, Ottawa, Ont
| | - R Auer
- From the University of Ottawa, Ottawa, Ont
| | - F Bellolio
- From the University of Toronto, Toronto, Ont
| | - Z Cohen
- From the University of Toronto, Toronto, Ont
| | - H MacRae
- From the University of Toronto, Toronto, Ont
| | - B O'Connor
- From the University of Toronto, Toronto, Ont
| | - H Huang
- From the University of Toronto, Toronto, Ont
| | - J C Victor
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - K Hardy
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - K Pitzul
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - J Kwong
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - A Vergis
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - D Urbach
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - A Okrainec
- From the University of Manitoba, Winnipeg, Man., the University of Toronto, Toronto, and Queen's University, Kingston, Ont
| | - K Vogt
- From the London Health Sciences Centre, London, Ont
| | - L Dubois
- From the London Health Sciences Centre, London, Ont
| | - C Vinden
- From the London Health Sciences Centre, London, Ont
| | - B Chan
- From the University of Ottawa, Ottawa, Ont
| | - A Scheer
- From the University of Ottawa, Ottawa, Ont
| | - A Menezes
- From the University of Ottawa, Ottawa, Ont
| | - H Moloo
- From the University of Ottawa, Ottawa, Ont
| | - E Poulin
- From the University of Ottawa, Ottawa, Ont
| | - R Boushey
- From the University of Ottawa, Ottawa, Ont
| | - J Mamazza
- From the University of Ottawa, Ottawa, Ont
| | - F Bellolio
- From the University of Toronto, Toronto, Ont
| | - H MacRae
- From the University of Toronto, Toronto, Ont
| | - Z Cohen
- From the University of Toronto, Toronto, Ont
| | - B O'Connor
- From the University of Toronto, Toronto, Ont
| | - H Huang
- From the University of Toronto, Toronto, Ont
| | - R McLeod
- From the University of Toronto, Toronto, Ont
| | - C Godbout-Simard
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - J Azar
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - F Psaradellis
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - J Sampalis
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - N Morin
- From the McGill Medical School, JSS Medical Research, Jewish General Hospital, Montréal, Que
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - S Kalikias
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - B Heidary
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - D Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - P T Phang
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - M Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, BC
| | - A Archibald
- From the Department of Pathology and the Gastrointestinal Diseases Research Unit, Queen's University, Kingston, Ont
| | - D Hurlbut
- From the Department of Pathology and the Gastrointestinal Diseases Research Unit, Queen's University, Kingston, Ont
| | - S Vanner
- From the Department of Pathology and the Gastrointestinal Diseases Research Unit, Queen's University, Kingston, Ont
| | - C Zalai
- From McGill University, Montréal, Que
| | | | - M Simunovic
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - M Cadeddu
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - S Forbes
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - S Kelly
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - W Stephen
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - V Grubac
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - M Marcinow
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - A Coates
- From the Juravinski Cancer Centre, McMaster University, Hamilton, Ont
| | - N Aslani
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - P T Phang
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - M Raval
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - C Brown
- From the University of British Columbia, Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - A Scheer
- From The Ottawa Hospital, Ottawa, Ont
| | - M Carrier
- From The Ottawa Hospital, Ottawa, Ont
| | - R Boushey
- From The Ottawa Hospital, Ottawa, Ont
| | - T Asmis
- From The Ottawa Hospital, Ottawa, Ont
| | - P Wells
- From The Ottawa Hospital, Ottawa, Ont
| | - D Jonker
- From The Ottawa Hospital, Ottawa, Ont
| | - R Auer
- From The Ottawa Hospital, Ottawa, Ont
| | - N Azer
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - R Gill
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - C de Gara
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - D W Birch
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - S Karmali
- From the University of Alberta, Royal Alexandra Hospital, Edmonton, Alta
| | - G Roxin
- From the University of Calgary, Calgary, Alta
| | - S Drolet
- From the University of Calgary, Calgary, Alta
| | - A MacLean
- From the University of Calgary, Calgary, Alta
| | - W D Buie
- From the University of Calgary, Calgary, Alta
| | - J Heine
- From the University of Calgary, Calgary, Alta
| | - J Agzarian
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - S Forbes
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - W Stephen
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - S Kelly
- From McMaster University Hamilton, Ont., and the Harvard School of Public Health, Boston, Mass
| | - P Churchill
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - T Corner
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - S Kelly
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - S Forbes
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - L Lindsay
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - W Stephen
- From McMaster University, Hamilton Health Sciences Hamilton, Ont
| | - A Scheer
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - A O'Connor
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - B Chan
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - H Moloo
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - E Poulin
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - J Mamazza
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - R Auer
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - R Boushey
- From The University of Ottawa, The Ottawa Hospital, Ottawa, Ont
| | - J Denis
- From the Winnipeg Regional Health Authority, University of Manitoba, Winnipeg, Man
| | - D Hochman
- From the Winnipeg Regional Health Authority, University of Manitoba, Winnipeg, Man
| | - M Recsky
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - P T Phang
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - M Raval
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - W Cheung
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, University of British Columbia, and the BC Cancer Agency, Vancouver, BC
| | - N Alkhamesi
- From Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - C M Schlachta
- From Canadian Surgical Technologies and Advanced Robotics, London, Ont
| | - T Tiwari
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - C Brown
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - M J Raval
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| | - P T Phang
- From the Department of Surgery, St. Paul's Hospital, Vancouver, BC
| |
Collapse
|